drug1	drug2	strength	RR	severity	patients.fem.mal	description	color	onethousand	fdr
Mesalazine	Azathioprine	0.383	-1.356	Moderate	369 (174/195)	The metabolism of Azathioprine can be decreased when combined with Mesalazine.	#B1CFE5	44.8837401657171	0
Haloperidol	Biperiden	0.488	-3.86	Moderate	176 (42/134)		#91B7D7	21.4079627890683	1.1522721326916e-313
Digoxin	Spironolactone	0.574	-1.109	Minor	23 (12/11)	The serum concentration of Digoxin can be increased when it is combined with Spironolactone.	#B4D1E6	2.79763150084416	9.83426645611571e-53
Digoxin	Amiodarone	0.619	1.102	Major	7 (4/3)	The serum concentration of Digoxin can be increased when it is combined with Amiodarone.	#F9BCBC	0.851453065474308	1.22553767954245e-15
Digoxin	Carvedilol	0.565	-1.383	Moderate	15 (7/8)	Digoxin may increase the bradycardic activities of Carvedilol.	#AFCEE4	1.82454228315923	2.95717704856508e-33
Digoxin	Furosemide	0.622	-1.774	Moderate	37 (15/22)	The risk or severity of adverse effects can be increased when Furosemide is combined with Digoxin.	#ABCBE2	4.50053763179277	6.13180808212121e-81
Carbamazepine	Levetiracetam	0.48	-1.589	Moderate	192 (83/109)	The risk or severity of adverse effects can be increased when Carbamazepine is combined with Levetiracetam.	#AECDE3	23.3541412244382	1.0975101907356e-241
Methotrexate	Hydroxychloroquine	0.325	7.085	Minor	67 (60/7)		#D66F6F	8.14962219811123	3.41675008668498e-90
Amiodarone	Acenocoumarol	0.432	-1.936	None	26 (10/16)	The therapeutic efficacy of Acenocoumarol can be increased when used in combination with Amiodarone.	#A9C9E1	3.162539957476	3.58697160587855e-53
Indomethacin	Methotrexate	0.396	1.555	Major	121 (79/42)	The serum concentration of Methotrexate can be increased when it is combined with Indomethacin.	#F6B6B6	14.7179744174845	3.05172113777823e-128
Omeprazole	Diazepam	0.534	1.359	Moderate	6904 (4293/2611)	The metabolism of Diazepam can be decreased when combined with Omeprazole.	#F7B9B9	839.775994862089	1
Valproic acid	Carbamazepine	0.479	-1.776	Moderate	190 (77/113)	The serum concentration of the active metabolites of Carbamazepine can be increased when Carbamazepine is used in combination with Valproic Acid.	#ABCBE2	23.1108689200169	5.98447998485651e-178
Lamotrigine	Carbamazepine	0.457	1.653	Moderate	87 (58/29)	The risk or severity of adverse effects can be increased when Lamotrigine is combined with Carbamazepine.	#F5B4B4	10.5823452423235	2.6773527222009e-87
Ethinylestradiol	Amoxicillin	0.186	1717.818	Moderate	6238 (6235/3)		#B32020	758.766317489819	1
Fluvoxamine	Clomipramine	0.412	-1.781	Major	89 (36/53)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Clomipramine.	#ABCBE2	10.8256175467448	4.50578331353429e-114
Trimethoprim	Leucovorin	0.594	-2.35	Major	153 (52/101)		#A5C6DF	18.6103312882242	1.11196295605278e-209
Propranolol	Rizatriptan	0.464	4.546	Moderate	195 (165/30)	The serum concentration of Rizatriptan can be increased when it is combined with Propranolol.	#E59090	23.71904968107	2.3676301775446e-106
Omeprazole	Alprazolam	0.369	1.581	Moderate	3230 (2121/1109)	The metabolism of Alprazolam can be decreased when combined with Omeprazole.	#F6B6B6	392.884771640288	1
Diltiazem	Buspirone	0.2	Inf	Moderate	1 (1/0)	The metabolism of Buspirone can be decreased when combined with Diltiazem.	#B32020	0.121636152210615	1
Mesalazine	Mercaptopurine	0.255	-1.21	Moderate	20 (10/10)	The metabolism of Mercaptopurine can be decreased when combined with Mesalazine.	#B2D0E5	2.43272304421231	7.62177289467608e-28
Atomoxetine	Propafenone	1	Inf	Moderate	1 (1/0)	The serum concentration of Atomoxetine can be increased when it is combined with Propafenone.	#B32020	0.121636152210615	1
Disopyramide	Bisoprolol	0.053	Inf	Major	1 (1/0)	Disopyramide may increase the bradycardic activities of Bisoprolol.	#B32020	0.121636152210615	1
Spironolactone	Enalapril	0.467	1.056	Major	41 (23/18)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Enalapril.	#F9BCBC	4.98708224063523	1.35573909335262e-38
Pravastatin	Fenofibrate	0.823	-3.831	Major	25 (6/19)	The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibrate is combined with Pravastatin.	#91B7D7	3.04090380526539	8.66935913813339e-38
Galantamine	Methotrimeprazine	0.1	Inf	Moderate	1 (1/0)	The metabolism of Galantamine can be decreased when combined with Methotrimeprazine.	#B32020	0.121636152210615	1
Omeprazole	Methotrexate	0.314	1.647	Major	377 (251/126)	The serum concentration of Methotrexate can be increased when it is combined with Omeprazole.	#F5B4B4	45.856829383402	2.02020824018736e-23
Trospium	Oxybutynin	1	Inf	Moderate	2 (2/0)	The risk or severity of adverse effects can be increased when Trospium is combined with Oxybutynin.	#B32020	0.243272304421231	0.0556408749477658
Fluoxetine	Clomipramine	0.359	1.189	Major	139 (82/57)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Clomipramine.	#F8BABA	16.9074251572755	2.42825231173451e-58
Omeprazole	Clonazepam	0.341	-1.088	Moderate	940 (495/445)		#B4D1E6	114.337983077979	1
Carbamazepine	Risperidone	0.4	-3.769	Moderate	107 (26/81)	The serum concentration of Risperidone can be decreased when it is combined with Carbamazepine.	#93B8D7	13.0150682865359	3.64868609182797e-86
Spironolactone	Tolevamer	0.327	Inf	Moderate	2 (2/0)		#B32020	0.243272304421231	0.0244656264013234
Topiramate	Carbamazepine	0.45	-1.407	Moderate	106 (49/57)	The serum concentration of Topiramate can be decreased when it is combined with Carbamazepine.	#AFCEE4	12.8934321343252	5.20883020991176e-62
Fluvoxamine	Olanzapine	0.331	-2.64	Moderate	70 (22/48)	The metabolism of Olanzapine can be decreased when combined with Fluvoxamine.	#A0C3DD	8.51453065474308	9.31080428574941e-53
Haloperidol	Lithium cation	0.455	-3.495	Major	35 (9/26)	Lithium may increase the neurotoxic activities of Haloperidol.	#96BBD9	4.25726532737154	1.08857232781327e-41
Phenytoin	Lamotrigine	0.357	-2.117	Moderate	22 (8/14)	The serum concentration of Lamotrigine can be decreased when it is combined with Phenytoin.	#A6C7E0	2.67599534863354	1.67373975606768e-25
Fluoxetine	Risperidone	0.382	-1.823	Moderate	178 (71/107)	The metabolism of Risperidone can be decreased when combined with Fluoxetine.	#ABCBE2	21.6512350934895	1.33391072329671e-51
Levothyroxine	Iron	0.265	68.437	Moderate	419 (414/5)	The serum concentration of Levothyroxine can be decreased when it is combined with Iron.	#B32020	50.9655477762479	1
Spironolactone	Captopril	0.601	1.653	Major	6 (4/2)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Captopril.	#F5B4B4	0.729816913263693	3.43267788409588e-07
Verapamil	Triazolam	1	Inf	Moderate	1 (1/0)	The metabolism of Triazolam can be decreased when combined with Verapamil.	#B32020	0.121636152210615	1
Raloxifene	Estriol	1	Inf	None	1 (1/0)		#B32020	0.121636152210615	1
Clozapine	Clonazepam	0.314	-4.083	Moderate	35 (8/27)	The risk or severity of adverse effects can be increased when Clonazepam is combined with Clozapine.	#8EB5D5	4.25726532737154	1.4930234751445e-36
Topiramate	Lithium cation	0.407	-1.377	Moderate	62 (29/33)	The serum concentration of Lithium can be increased when it is combined with Topiramate.	#AFCEE4	7.54144143705816	1.11718382611747e-35
Pyridostigmine	Prednisone	0.464	5.786	Moderate	32 (28/4)	The risk or severity of adverse effects can be increased when Prednisone is combined with Pyridostigmine.	#DE8080	3.89235687073969	8.7955670079572e-16
Warfarin	Amiodarone	0.8	-1.21	Major	2 (1/1)	The therapeutic efficacy of Warfarin can be increased when used in combination with Amiodarone.	#B2D0E5	0.243272304421231	0.0785740381209023
Phenytoin	Vigabatrin	0.25	Inf	Minor	1 (1/0)	The serum concentration of Phenytoin can be decreased when it is combined with Vigabatrin.	#B32020	0.121636152210615	1
Sulfasalazine	Azathioprine	0.315	1.929	Moderate	10 (7/3)		#F4B1B1	1.21636152210615	3.55451059796174e-07
Prednisone	Ethinylestradiol	0.204	Inf	Moderate	632 (632/0)	The serum concentration of Prednisone can be increased when it is combined with Ethinyl Estradiol.	#B32020	76.8740481971089	1
Diltiazem	Amiodarone	0.908	-3.63	Major	4 (1/3)	The risk or severity of bradycardia can be increased when Diltiazem is combined with Amiodarone.	#94B9D8	0.486544608842462	1.66292054294077e-06
Tacrolimus	Atorvastatin	0.359	-1.783	Moderate	47 (19/28)	The risk or severity of adverse effects can be increased when Tacrolimus is combined with Atorvastatin.	#ABCBE2	5.71689915389893	5.36931961597943e-29
Colestipol	Ursodeoxycholic acid	0.25	Inf	None	1 (1/0)	The serum concentration of Ursodeoxycholic acid can be decreased when it is combined with Colestipol.	#B32020	0.121636152210615	1
Galantamine	Risperidone	0.333	Inf	Moderate	1 (1/0)		#B32020	0.121636152210615	1
Sucralfate	Lansoprazole	0.468	1.653	Moderate	33 (22/11)		#F5B4B4	4.01399302295031	2.48174589109873e-14
Fluvoxamine	Moclobemide	0.1	Inf	None	1 (1/0)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Moclobemide.	#B32020	0.121636152210615	1
Fluvoxamine	Lithium cation	0.339	-1.664	Major	19 (8/11)	Lithium may increase the serotonergic activities of Fluvoxamine.	#ACCCE3	2.31108689200169	2.97598626621265e-15
Simvastatin	Fenofibrate	0.468	-2.178	Major	28 (10/18)	The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibrate is combined with Simvastatin.	#A6C7E0	3.40581226189723	5.94770772540884e-16
Repaglinide	Glyburide	0.364	Inf	None	1 (1/0)	Repaglinide may increase the hypoglycemic activities of Glyburide.	#B32020	0.121636152210615	1
Ramipril	Spironolactone	0.527	1.102	Major	7 (4/3)	The risk or severity of adverse effects can be increased when Ramipril is combined with Spironolactone.	#F9BCBC	0.851453065474308	1.6531228303152e-05
Amitriptyline	Duloxetine	0.389	4.629	Major	66 (56/10)	Duloxetine may increase the serotonergic activities of Amitriptyline.	#E48E8E	8.02798604590062	5.03118741504231e-08
Methotrexate	Naproxen	0.326	2.279	Major	139 (102/37)	The serum concentration of Methotrexate can be increased when it is combined with Naproxen.	#F2ACAC	16.9074251572755	1
Fenofibrate	Atorvastatin	0.492	-5.243	Major	32 (6/26)	The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibrate is combined with Atorvastatin.	#80ABCF	3.89235687073969	7.70999776213475e-31
Acetaminophen	Acenocoumarol	0.266	-1.33	None	296 (141/155)	Acetaminophen may increase the anticoagulant activities of Acenocoumarol.	#B1CFE5	36.0043010543422	1
Propranolol	Ibuprofen	0.337	2.492	Moderate	526 (395/131)	Ibuprofen may decrease the antihypertensive activities of Propranolol.	#F0A9A9	63.9806160627837	1
Cyclosporine	Sirolimus	0.031	Inf	Moderate	1 (1/0)	The risk or severity of adverse effects can be increased when Sirolimus is combined with Cyclosporine.	#B32020	0.121636152210615	1
Propranolol	Sertraline	0.39	1.446	Moderate	99 (63/36)	The metabolism of Propranolol can be decreased when combined with Sertraline.	#F7B7B7	12.0419790688509	1.9980301304612e-07
Digoxin	Hydrochlorothiazide	0.365	-1.613	Moderate	7 (3/4)	The risk or severity of adverse effects can be increased when Hydrochlorothiazide is combined with Digoxin.	#AECDE3	0.851453065474308	1.65736940834932e-06
Paroxetine	Risperidone	0.374	-2.773	Moderate	158 (48/110)	The metabolism of Risperidone can be decreased when combined with Paroxetine.	#9FC1DD	19.2185120492772	8.72635693415882e-16
Haloperidol	Carbamazepine	0.385	-4.436	Moderate	28 (6/22)	The metabolism of Haloperidol can be increased when combined with Carbamazepine.	#8BB3D4	3.40581226189723	5.19528937779171e-24
Cyclosporine	Methotrexate	0.183	-1.815	Moderate	15 (6/9)	The serum concentration of Methotrexate can be increased when it is combined with Cyclosporine.	#ABCBE2	1.82454228315923	2.65722391381958e-12
Propranolol	Paroxetine	0.32	2.089	Moderate	127 (91/36)	The metabolism of Propranolol can be decreased when combined with Paroxetine.	#F3AFAF	15.4477913307482	1
Cyclosporine	Sulfamethoxazole	0.465	-1.882	Major	23 (9/14)	Sulfamethoxazole may increase the nephrotoxic activities of Cyclosporine.	#A9C9E1	2.79763150084416	7.6006782559289e-16
Trospium	Risperidone	0.341	-1.21	Moderate	4 (2/2)		#B2D0E5	0.486544608842462	0.00523773506748524
Sumatriptan	Ergotamine	0.687	2.112	Major	32 (23/9)	Ergotamine may increase the vasoconstricting activities of Sumatriptan.	#F2AEAE	3.89235687073969	2.67589413740311e-11
Trihexyphenidyl	Haloperidol	0.661	-13.309	Moderate	12 (1/11)		#1E61A5	1.45963382652739	8.81013512566453e-22
Atenolol	Diltiazem	0.285	1.24	Major	5 (3/2)	Diltiazem may increase the hypotensive activities of Atenolol.	#F8BABA	0.608180761053077	0.00319518126667538
Propranolol	Escitalopram	0.36	1.053	None	116 (65/51)		#F9BCBC	14.1097936564314	2.72702730979425e-06
Amitriptyline	Fluoxetine	0.335	3.494	Major	115 (93/22)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Amitriptyline.	#EB9C9C	13.9881575042208	1
Prednisone	Acetylsalicylic acid	0.447	2.263	Moderate	157 (115/42)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Prednisone.	#F2ACAC	19.0968758970666	1
Carbamazepine	Midazolam	0.26	-2.662	Moderate	16 (5/11)	The metabolism of Midazolam can be increased when combined with Carbamazepine.	#A0C3DD	1.94617843536985	1.79053057106345e-13
Moclobemide	Clomipramine	0.085	-1.21	None	2 (1/1)	Moclobemide may increase the serotonergic activities of Clomipramine.	#B2D0E5	0.243272304421231	0.511421439743157
Cyclosporine	Carvedilol	0.4	-1.21	Moderate	4 (2/2)	The serum concentration of Cyclosporine can be increased when it is combined with Carvedilol.	#B2D0E5	0.486544608842462	0.0158607059134966
Acetylsalicylic acid	Ibuprofen	0.415	1.279	Major	558 (339/219)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Ibuprofen.	#F7B9B9	67.8729729335234	1
Ziprasidone	Pimozide	0.603	-1.21	Major	2 (1/1)	The serum concentration of Pimozide can be increased when it is combined with Ziprasidone.	#B2D0E5	0.243272304421231	1
Phenobarbital	Estriol	0.037	Inf	None	1 (1/0)		#B32020	0.121636152210615	1
Ziprasidone	Chlorpromazine	0.377	-3.63	Major	4 (1/3)	Chlorpromazine may increase the QTc-prolonging activities of Ziprasidone.	#94B9D8	0.486544608842462	0.000902400364308389
Cyclosporine	Atorvastatin	0.321	1.033	Major	9 (5/4)	The serum concentration of Atorvastatin can be increased when it is combined with Cyclosporine.	#F9BCBC	1.09472536989554	0.000254219519404063
Cyclosporine	Omeprazole	0.331	-1.233	Moderate	105 (52/53)	The serum concentration of Cyclosporine can be increased when it is combined with Omeprazole.	#B2D0E5	12.7717959821146	1
Atenolol	Clonidine	0.818	Inf	Major	1 (1/0)	Clonidine may increase the atrioventricular blocking (AV block) activities of Atenolol.	#B32020	0.121636152210615	1
Fluvastatin	Colchicine	0.1	Inf	Major	1 (1/0)	Colchicine may increase the myopathic rhabdomyolysis activities of Fluvastatin.	#B32020	0.121636152210615	1
Phenytoin	Conjugated estrogens	0.188	Inf	Moderate	1 (1/0)	The therapeutic efficacy of Conjugated estrogens can be decreased when used in combination with Phenytoin.	#B32020	0.121636152210615	1
Methadone	Carbamazepine	0.5	Inf	Major	1 (1/0)	The metabolism of Methadone can be increased when combined with Carbamazepine.	#B32020	0.121636152210615	1
Doxycycline	Ethinylestradiol	0.289	Inf	Moderate	212 (212/0)	The metabolism of Ethinyl Estradiol can be decreased when combined with Doxycycline.	#B32020	25.7868642686505	1
Prednisone	Estradiol	0.157	152.909	Moderate	186 (185/1)	The serum concentration of Prednisone can be increased when it is combined with Estradiol.	#B32020	22.6243243111745	1
Imipramine	Fluoxetine	0.294	1.299	Major	18 (11/7)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Imipramine.	#F7B9B9	2.18945073979108	3.71492132056608e-07
Imipramine	Duloxetine	0.215	-1.452	Major	11 (5/6)	Duloxetine may increase the serotonergic activities of Imipramine.	#AFCEE4	1.33799767431677	5.80654582324343e-08
Cyclosporine	Amiodarone	0.059	Inf	Moderate	1 (1/0)	The serum concentration of Cyclosporine can be increased when it is combined with Amiodarone.	#B32020	0.121636152210615	1
Fluoxetine	Nortriptyline	0.585	1.446	Major	11 (7/4)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Nortriptyline.	#F7B7B7	1.33799767431677	9.0214058085373e-06
Citalopram	Propranolol	0.303	2.225	Moderate	96 (70/26)	The metabolism of Propranolol can be decreased when combined with Citalopram.	#F2AEAE	11.6770706122191	1
Fluvoxamine	Doxepin	0.333	Inf	Major	1 (1/0)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Doxepin.	#B32020	0.121636152210615	1
Fluoxetine	Propranolol	0.353	1.626	Moderate	89 (59/30)	The metabolism of Propranolol can be decreased when combined with Fluoxetine.	#F5B4B4	10.8256175467448	0.864717839611258
Ethinylestradiol	Itraconazole	0.266	Inf	Moderate	199 (199/0)	The metabolism of Ethinyl Estradiol can be decreased when combined with Itraconazole.	#B32020	24.2055942899125	1
Trospium	Solifenacin	0.25	Inf	Moderate	1 (1/0)	The risk or severity of adverse effects can be increased when Trospium is combined with Solifenacin.	#B32020	0.121636152210615	1
Pioglitazone	Gemfibrozil	0.303	-1.21	Major	2 (1/1)	The metabolism of Pioglitazone can be decreased when combined with Gemfibrozil.	#B2D0E5	0.243272304421231	1
Acitretin	Methotrexate	0.163	-3.63	Major	4 (1/3)	Acitretin may increase the hepatotoxic activities of Methotrexate.	#94B9D8	0.486544608842462	0.0620382729409388
Acitretin	Norethisterone	0.2	Inf	None	1 (1/0)		#B32020	0.121636152210615	1
Acetylsalicylic acid	Acenocoumarol	0.434	-1.383	None	30 (14/16)	Acetylsalicylic acid may increase the anticoagulant activities of Acenocoumarol.	#AFCEE4	3.64908456631846	4.25603811157231e-08
Donepezil	Quetiapine	1	Inf	Moderate	1 (1/0)		#B32020	0.121636152210615	1
Atorvastatin	Gemfibrozil	0.582	-3.388	Major	19 (5/14)	The risk or severity of adverse effects can be increased when Gemfibrozil is combined with Atorvastatin.	#97BCD9	2.31108689200169	1.24500879892718e-09
Cholestyramine	Ursodeoxycholic acid	0.561	-2.42	None	9 (3/6)	The serum concentration of Ursodeoxycholic acid can be decreased when it is combined with Cholestyramine.	#A3C5DF	1.09472536989554	2.50603763127096e-09
Phenytoin	Topiramate	0.374	-1.613	Moderate	14 (6/8)	The serum concentration of Phenytoin can be increased when it is combined with Topiramate.	#AECDE3	1.70290613094862	5.28368906281666e-06
Gentamicin	Ceftriaxone	1	Inf	Moderate	1 (1/0)		#B32020	0.121636152210615	1
Zolmitriptan	Ergotamine	0.584	2.362	Major	27 (20/7)	Ergotamine may increase the vasoconstricting activities of Zolmitriptan.	#F1ABAB	3.28417610968662	6.93217037609172e-06
Duloxetine	Nortriptyline	0.469	1.24	Major	5 (3/2)	Duloxetine may increase the serotonergic activities of Nortriptyline.	#F8BABA	0.608180761053077	0.00473176077554569
Carbamazepine	Simvastatin	0.326	-1.21	Moderate	24 (12/12)	The metabolism of Simvastatin can be increased when combined with Carbamazepine.	#B2D0E5	2.91926765305477	0.00022685086209639
Alprazolam	Clarithromycin	0.311	2.273	Moderate	300 (220/80)	The serum concentration of Alprazolam can be increased when it is combined with Clarithromycin.	#F2ACAC	36.4908456631846	1
Nortriptyline	Carbamazepine	0.25	Inf	Moderate	2 (2/0)	The metabolism of Nortriptyline can be increased when combined with Carbamazepine.	#B32020	0.243272304421231	1
Clonidine	Clomipramine	0.483	-1.21	Major	2 (1/1)	Clomipramine may decrease the antihypertensive activities of Clonidine.	#B2D0E5	0.243272304421231	1
Phenoxymethylpenicillin	Ethinylestradiol	0.165	Inf	Moderate	168 (168/0)		#B32020	20.4348735713834	1
Ergotamine	Rizatriptan	0.662	3.926	Major	23 (19/4)	Ergotamine may increase the vasoconstricting activities of Rizatriptan.	#E89898	2.79763150084416	0.00120367278977635
Fluoxetine	Lithium cation	0.334	-1.274	Major	39 (19/20)	Lithium may increase the serotonergic activities of Fluoxetine.	#B1CFE5	4.743809936214	2.89641217829357e-06
Simvastatin	Gemfibrozil	0.341	-3.457	Major	27 (7/20)	The risk or severity of rhabdomyolysis. myoglobinuria. and elevated creatine kinase (CPK) can be increased when Gemfibrozil is combined with Simvastatin.	#97BCD9	3.28417610968662	1.2754598932327e-09
Fluphenazine	Bromocriptine	0.111	Inf	Moderate	1 (1/0)	The therapeutic efficacy of Fluphenazine can be decreased when used in combination with Bromocriptine.	#B32020	0.121636152210615	1
Lovastatin	Carbamazepine	0.044	1.653	None	3 (2/1)	The metabolism of Lovastatin can be increased when combined with Carbamazepine.	#F5B4B4	0.364908456631846	0.989989288980138
Propranolol	Ergotamine	0.656	7.852	Moderate	21 (19/2)	Ergotamine may increase the atrioventricular blocking (AV block) activities of Propranolol.	#D26565	2.55435919642292	0.114937556282326
Phenytoin	Fludrocortisone	0.857	Inf	Moderate	1 (1/0)	The serum concentration of Fludrocortisone can be decreased when it is combined with Phenytoin.	#B32020	0.121636152210615	1
Omeprazole	Ketazolam	0.505	-1.059	None	150 (80/70)		#B4D1E6	18.2454228315923	1
Tramadol	Carbamazepine	0.516	2.232	Moderate	37 (27/10)	Tramadol may increase the central nervous system depressant (CNS depressant) activities of Carbamazepine.	#F2ACAC	4.50053763179277	1
Carbamazepine	Aripiprazole	0.392	-3.63	Moderate	32 (8/24)	The serum concentration of Aripiprazole can be decreased when it is combined with Carbamazepine.	#94B9D8	3.89235687073969	2.07887514774657e-14
Mirtazapine	Donepezil	0.568	Inf	Moderate	1 (1/0)		#B32020	0.121636152210615	1
Tramadol	Fluoxetine	0.325	2.423	Major	114 (85/29)	Fluoxetine may increase the neuroexcitatory activities of Tramadol.	#F1ABAB	13.8665213520102	1
Warfarin	Phenobarbital	0.66	Inf	Major	1 (1/0)	The metabolism of Warfarin can be increased when combined with Phenobarbital.	#B32020	0.121636152210615	1
Methotrexate	Acetylsalicylic acid	0.276	4.408	Major	19 (16/3)	The serum concentration of Methotrexate can be increased when it is combined with Acetylsalicylic acid.	#E69191	2.31108689200169	1
Tramadol	Citalopram	0.326	1.996	Major	140 (99/41)	Citalopram may increase the neuroexcitatory activities of Tramadol.	#F3AFAF	17.0290613094862	1
Trimethoprim	Rifampicin	0.566	-1.748	Moderate	22 (9/13)	The metabolism of Trimethoprim can be increased when combined with Rifampicin.	#ABCBE2	2.67599534863354	1.11834633161504e-06
Acetylsalicylic acid	Glyburide	0.868	-1.21	Moderate	10 (5/5)	Acetylsalicylic acid may increase the hypoglycemic activities of Glyburide.	#B2D0E5	1.21636152210615	0.000339041213822211
Carbamazepine	Atorvastatin	0.207	1.446	Moderate	11 (7/4)	The metabolism of Atorvastatin can be increased when combined with Carbamazepine.	#F7B7B7	1.33799767431677	0.286492337176775
Atenolol	Glyburide	0.867	-2.42	Moderate	6 (2/4)	Atenolol may increase the hypoglycemic activities of Glyburide.	#A3C5DF	0.729816913263693	0.000153642329649468
Tramadol	Paroxetine	0.326	1.884	Major	141 (98/43)	Paroxetine may increase the neuroexcitatory activities of Tramadol.	#F4B1B1	17.1506974616968	1
Cyclosporine	Tacrolimus	0.149	-1.452	Major	11 (5/6)	Tacrolimus may increase the nephrotoxic activities of Cyclosporine.	#AFCEE4	1.33799767431677	0.000222518638830699
Dihydroergotamine	Propranolol	0.717	5.372	Moderate	15 (13/2)	Dihydroergotamine may increase the atrioventricular blocking (AV block) activities of Propranolol.	#E08585	1.82454228315923	0.130430493230265
Amitriptyline	Carbamazepine	0.349	1.653	Moderate	30 (20/10)	The metabolism of Amitriptyline can be increased when combined with Carbamazepine.	#F5B4B4	3.64908456631846	1
Ethinylestradiol	Cloxacillin	0.206	Inf	Moderate	190 (190/0)		#B32020	23.1108689200169	1
Fluconazole	Alprazolam	0.308	3.909	Major	212 (175/37)	The metabolism of Alprazolam can be decreased when combined with Fluconazole.	#E89898	25.7868642686505	1
Prednisone	Acenocoumarol	0.347	1.264	None	43 (26/17)		#F7B9B9	5.23035454505646	1
Tramadol	Escitalopram	0.299	2.48	Major	96 (72/24)	Escitalopram may increase the neuroexcitatory activities of Tramadol.	#F0A9A9	11.6770706122191	1
Phenytoin	Oxcarbazepine	0.298	-4.235	Moderate	9 (2/7)	The serum concentration of the active metabolites of Oxcarbazepine can be reduced when Oxcarbazepine is used in combination with Phenytoin resulting in a loss in efficacy.	#8CB4D5	1.09472536989554	3.59249543417439e-06
Tizanidine	Ethinylestradiol	0.203	Inf	Major	85 (85/0)		#B32020	10.3390729379023	1
Phenytoin	Diazepam	0.286	-1.495	Moderate	38 (17/21)	The serum concentration of Phenytoin can be increased when it is combined with Diazepam.	#AECDE3	4.62217378400339	1
Bisoprolol	Glyburide	0.392	1.653	Moderate	3 (2/1)	Bisoprolol may increase the hypoglycemic activities of Glyburide.	#F5B4B4	0.364908456631846	1
Fluvastatin	Cholestyramine	0.109	Inf	Moderate	1 (1/0)	The serum concentration of Fluvastatin can be decreased when it is combined with Cholestyramine.	#B32020	0.121636152210615	1
Omeprazole	Itraconazole	0.461	1.505	Moderate	299 (193/106)	The serum concentration of Itraconazole can be decreased when it is combined with Omeprazole.	#F6B6B6	36.369209510974	1
Acetylsalicylic acid	Insulin aspart	0.373	1.033	Moderate	36 (20/16)	Acetylsalicylic acid may increase the hypoglycemic activities of Insulin Aspart.	#F9BCBC	4.37890147958216	1
Venlafaxine	Metoclopramide	0.221	3.437	Moderate	98 (79/19)	The risk or severity of adverse effects can be increased when Metoclopramide is combined with Venlafaxine.	#EB9E9E	11.9203429166403	1
Rizatriptan	Escitalopram	0.269	4.133	Major	48 (40/8)	The risk or severity of adverse effects can be increased when Rizatriptan is combined with Escitalopram.	#E79494	5.83853530610954	1
Methotrexate	Amoxicillin	0.161	1.685	Major	155 (104/51)	The serum concentration of Methotrexate can be increased when it is combined with Amoxicillin.	#F5B4B4	18.8536035926454	1
Diltiazem	Simvastatin	0.732	-1.613	Major	7 (3/4)	The serum concentration of Simvastatin can be increased when it is combined with Diltiazem.	#AECDE3	0.851453065474308	0.00203091480290037
Amitriptyline	Salbutamol	0.304	4.061	Moderate	136 (113/23)	The risk or severity of adverse effects can be increased when Amitriptyline is combined with Salbutamol.	#E89696	16.5425167006437	1
Fluoxetine	Trimipramine	0.417	-1.21	Major	2 (1/1)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Trimipramine.	#B2D0E5	0.243272304421231	1
Carbamazepine	Oxybutynin	0.492	-1.21	None	6 (3/3)	The metabolism of Oxybutynin can be increased when combined with Carbamazepine.	#B2D0E5	0.729816913263693	0.0555919084319408
Zolmitriptan	Escitalopram	0.287	3.49	Major	47 (38/9)	The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Escitalopram.	#EB9C9C	5.71689915389893	1
Paroxetine	Rizatriptan	0.237	5.063	Major	57 (49/8)	The risk or severity of adverse effects can be increased when Paroxetine is combined with Rizatriptan.	#E18888	6.93326067600508	1
Diazepam	Clarithromycin	0.481	2.242	Moderate	297 (217/80)	The metabolism of Diazepam can be decreased when combined with Clarithromycin.	#F2ACAC	36.1259372065528	1
Doxycycline	Amoxicillin	0.509	1.072	Moderate	510 (288/222)	The therapeutic efficacy of Amoxicillin can be decreased when used in combination with Doxycycline.	#F9BCBC	62.0344376274139	1
Fluvastatin	Gemfibrozil	0.125	Inf	Major	1 (1/0)	The risk or severity of rhabdomyolysis. myoglobinuria. and elevated creatine kinase (CPK) can be increased when Gemfibrozil is combined with Fluvastatin.	#B32020	0.121636152210615	1
Citalopram	Clarithromycin	0.32	3.245	Major	133 (106/27)	Clarithromycin may increase the QTc-prolonging activities of Citalopram.	#EC9F9F	16.1776082440119	1
Alprazolam	Carbamazepine	0.286	-1.072	Moderate	66 (35/31)	The metabolism of Alprazolam can be increased when combined with Carbamazepine.	#B4D1E6	8.02798604590062	1
Citalopram	Rizatriptan	0.298	4.753	Major	54 (46/8)	The risk or severity of adverse effects can be increased when Citalopram is combined with Rizatriptan.	#E38D8D	6.56835221937323	1
Carbamazepine	Dextropropoxyphene	0.273	-1.21	None	2 (1/1)	The metabolism of Dextropropoxyphene can be increased when combined with Carbamazepine.	#B2D0E5	0.243272304421231	1
Cyclosporine	Ursodeoxycholic acid	0.611	1.653	Minor	3 (2/1)		#F5B4B4	0.364908456631846	1
Topiramate	Ethinylestradiol	0.217	Inf	Moderate	98 (98/0)	The serum concentration of Ethinyl Estradiol can be decreased when it is combined with Topiramate.	#B32020	11.9203429166403	1
Ibuprofen	Lithium cation	0.13	-1.21	Moderate	140 (70/70)	The serum concentration of Lithium can be increased when it is combined with Ibuprofen.	#B2D0E5	17.0290613094862	1
Omeprazole	Midazolam	0.281	1.498	Moderate	45 (29/16)		#F6B6B6	5.47362684947769	1
Cyclosporine	Diltiazem	0.188	Inf	Moderate	1 (1/0)	The metabolism of Cyclosporine can be decreased when combined with Diltiazem.	#B32020	0.121636152210615	1
Bisoprolol	Ibuprofen	0.289	-1.059	Moderate	165 (88/77)	Ibuprofen may decrease the antihypertensive activities of Bisoprolol.	#B4D1E6	20.0699651147515	1
Citalopram	Zolmitriptan	0.254	4.546	Major	52 (44/8)	The risk or severity of adverse effects can be increased when Citalopram is combined with Zolmitriptan.	#E59090	6.325079914952	1
Fludrocortisone	Phenobarbital	0.833	Inf	Moderate	1 (1/0)	The serum concentration of Fludrocortisone can be decreased when it is combined with Phenobarbital.	#B32020	0.121636152210615	1
Methotrexate	Diclofenac	0.322	2.775	Major	61 (47/14)	The serum concentration of Methotrexate can be increased when it is combined with Diclofenac.	#EFA6A6	7.41980528484754	1
Carbamazepine	Sertraline	0.339	-1.855	Moderate	38 (15/23)	The metabolism of Carbamazepine can be decreased when combined with Sertraline.	#ABCBE2	4.62217378400339	0.0102326227180065
Spironolactone	Losartan	0.35	-2.42	Major	6 (2/4)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Losartan.	#A3C5DF	0.729816913263693	0.00084953253855558
Methylphenidate	Carbamazepine	0.323	-1.452	None	11 (5/6)		#AFCEE4	1.33799767431677	1
Fluoxetine	Oxycodone	0.26	Inf	Moderate	6 (6/0)	The metabolism of Oxycodone can be decreased when combined with Fluoxetine.	#B32020	0.729816913263693	1
Fentanyl	Rifampicin	0.2	-1.21	Major	4 (2/2)	The serum concentration of Fentanyl can be decreased when it is combined with Rifampicin.	#B2D0E5	0.486544608842462	0.598658080084282
Methotrexate	Ibuprofen	0.216	2.055	Major	122 (87/35)	The serum concentration of Methotrexate can be increased when it is combined with Ibuprofen.	#F3AFAF	14.8396105696951	1
Eletriptan	Paroxetine	0.466	6.612	Major	18 (16/2)	The metabolism of Eletriptan can be decreased when combined with Paroxetine.	#D97575	2.18945073979108	1
Fluvoxamine	Nortriptyline	0.561	-1.21	Major	2 (1/1)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Nortriptyline.	#B2D0E5	0.243272304421231	1
Tetracycline	Ethinylestradiol	0.292	Inf	None	37 (37/0)		#B32020	4.50053763179277	1
Fluconazole	Diazepam	0.416	3.154	Moderate	236 (187/49)	The metabolism of Diazepam can be decreased when combined with Fluconazole.	#EDA1A1	28.7061319217052	1
Atenolol	Ibuprofen	0.273	-1.226	Moderate	155 (77/78)	Ibuprofen may decrease the antihypertensive activities of Atenolol.	#B2D0E5	18.8536035926454	1
Furosemide	Ibuprofen	0.342	1.676	Moderate	109 (73/36)	The therapeutic efficacy of Furosemide can be decreased when used in combination with Ibuprofen.	#F5B4B4	13.2583405909571	1
Ergotamine	Nadolol	0.414	Inf	Moderate	5 (5/0)	Ergotamine may increase the atrioventricular blocking (AV block) activities of Nadolol.	#B32020	0.608180761053077	1
Levothyroxine	Raloxifene	0.088	Inf	Moderate	5 (5/0)	Raloxifene can cause a decrease in the absorption of Levothyroxine resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B32020	0.608180761053077	0.835225889567948
Bisoprolol	Gliclazide	0.527	-1.21	None	4 (2/2)	Bisoprolol may increase the hypoglycemic activities of Gliclazide.	#B2D0E5	0.486544608842462	0.820596117079781
Azathioprine	Acenocoumarol	0.491	-1.512	None	9 (4/5)	Azathioprine may decrease the anticoagulant activities of Acenocoumarol.	#AECDE3	1.09472536989554	0.0389670287775249
Phenytoin	Omeprazole	0.417	-2.285	Moderate	52 (18/34)	The serum concentration of Omeprazole can be decreased when it is combined with Phenytoin.	#A5C6DF	6.325079914952	1
Valproic acid	Acetylsalicylic acid	0.199	-2.064	Moderate	46 (17/29)	The serum concentration of Valproic Acid can be increased when it is combined with Acetylsalicylic acid.	#A8C8E1	5.59526300168831	1
Zolmitriptan	Paroxetine	0.239	3.389	Major	51 (41/10)	The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Paroxetine.	#EB9E9E	6.20344376274139	1
Almotriptan	Escitalopram	0.297	4.339	Major	25 (21/4)	The risk or severity of adverse effects can be increased when Almotriptan is combined with Escitalopram.	#E69191	3.04090380526539	1
Dextromethorphan	Paroxetine	0.244	2.24	Major	115 (84/31)	Paroxetine may increase the serotonergic activities of Dextromethorphan.	#F2ACAC	13.9881575042208	1
Acetylsalicylic acid	Methylprednisolone	0.536	5.51	Moderate	23 (20/3)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Methylprednisolone.	#DF8383	2.79763150084416	1
Trazodone	Acenocoumarol	0.164	Inf	None	5 (5/0)		#B32020	0.608180761053077	1
Duloxetine	Propafenone	0.062	Inf	Moderate	1 (1/0)	The serum concentration of Duloxetine can be increased when it is combined with Propafenone.	#B32020	0.121636152210615	1
Fluvastatin	Acenocoumarol	0.541	Inf	None	1 (1/0)	The metabolism of Acenocoumarol can be decreased when combined with Fluvastatin.	#B32020	0.121636152210615	1
Ibuprofen	Nadolol	0.313	3.361	Moderate	76 (61/15)	Ibuprofen may decrease the antihypertensive activities of Nadolol.	#EB9E9E	9.24434756800677	1
Venlafaxine	Almotriptan	0.134	10.745	Major	14 (13/1)	The risk or severity of adverse effects can be increased when Venlafaxine is combined with Almotriptan.	#C13F3F	1.70290613094862	1
Fenofibrate	Rosuvastatin	0.586	-3.63	Major	4 (1/3)	The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibrate is combined with Rosuvastatin.	#94B9D8	0.486544608842462	0.0596934278547778
Dihydroergotamine	Sumatriptan	0.675	-1.059	Major	15 (8/7)	Dihydroergotamine may increase the vasoconstricting activities of Sumatriptan.	#B4D1E6	1.82454228315923	0.00252267678468415
Fluoxetine	Clarithromycin	0.202	8.502	Moderate	79 (72/7)	Clarithromycin may increase the QTc-prolonging activities of Fluoxetine.	#CE5D5D	9.60925602463862	1
Acetaminophen	Isoniazid	0.283	-1.538	Moderate	159 (70/89)	The risk or severity of adverse effects can be increased when Isoniazid is combined with Acetaminophen.	#AECDE3	19.3401482014879	1
Fluoxetine	Sumatriptan	0.253	23.143	Major	29 (28/1)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Sumatriptan.	#B32020	3.52744841410785	1
Pimozide	Sertraline	0.501	-1.613	Major	7 (3/4)	Sertraline may increase the QTc-prolonging activities of Pimozide.	#AECDE3	0.851453065474308	0.349020113666412
Omeprazole	Halazepam	0.296	2.598	Moderate	29 (22/7)		#F0A9A9	3.52744841410785	1
Fluoxetine	Rizatriptan	0.203	25.623	Major	32 (31/1)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Rizatriptan.	#B32020	3.89235687073969	1
Acetylsalicylic acid	Gliclazide	0.621	-1.815	None	10 (4/6)	Acetylsalicylic acid may increase the hypoglycemic activities of Gliclazide.	#ABCBE2	1.21636152210615	0.0205397108443893
Fluvoxamine	Duloxetine	0.319	1.033	Major	9 (5/4)	The serum concentration of Duloxetine can be increased when it is combined with Fluvoxamine.	#F9BCBC	1.09472536989554	1
Methotrexate	Sulfamethoxazole	0.158	1.929	Moderate	10 (7/3)	The risk or severity of adverse effects can be increased when Sulfamethoxazole is combined with Methotrexate.	#F4B1B1	1.21636152210615	1
Carvedilol	Insulin detemir	0.1	Inf	Moderate	1 (1/0)		#B32020	0.121636152210615	1
Ibuprofen	Acenocoumarol	0.192	-1.165	None	106 (54/52)	Ibuprofen may increase the anticoagulant activities of Acenocoumarol.	#B2D0E5	12.8934321343252	1
Cyclosporine	Colchicine	0.231	-3.63	Major	4 (1/3)	The serum concentration of Colchicine can be increased when it is combined with Cyclosporine.	#94B9D8	0.486544608842462	0.0795468121084702
Alprazolam	Itraconazole	0.366	2.513	Major	101 (76/25)	The serum concentration of Alprazolam can be increased when it is combined with Itraconazole.	#F0A9A9	12.2852513732722	1
Trimethoprim	Methotrexate	0.158	1.929	Major	10 (7/3)	The risk or severity of adverse effects can be increased when Trimethoprim is combined with Methotrexate.	#F4B1B1	1.21636152210615	1
Levothyroxine	Acenocoumarol	0.339	1.535	None	20 (13/7)	Levothyroxine may increase the anticoagulant activities of Acenocoumarol.	#F6B6B6	2.43272304421231	1
Ethinylestradiol	Minocycline	0.236	Inf	Moderate	62 (62/0)		#B32020	7.54144143705816	1
Chlorpromazine	Bromocriptine	0.5	Inf	Moderate	1 (1/0)	The therapeutic efficacy of Chlorpromazine can be decreased when used in combination with Bromocriptine.	#B32020	0.121636152210615	1
Sumatriptan	Escitalopram	0.267	19.837	Major	25 (24/1)	The risk or severity of adverse effects can be increased when Sumatriptan is combined with Escitalopram.	#B32020	3.04090380526539	1
Citalopram	Sumatriptan	0.299	4.133	Major	36 (30/6)	The risk or severity of adverse effects can be increased when Citalopram is combined with Sumatriptan.	#E79494	4.37890147958216	1
Sertraline	Clarithromycin	0.171	1.991	Moderate	75 (53/22)	The metabolism of Sertraline can be decreased when combined with Clarithromycin.	#F3AFAF	9.12271141579616	1
Digoxin	Levothyroxine	0.184	3.306	Moderate	5 (4/1)		#EC9F9F	0.608180761053077	1
Cyclosporine	Pravastatin	0.616	-2.42	Major	3 (1/2)	The serum concentration of Pravastatin can be increased when it is combined with Cyclosporine.	#A3C5DF	0.364908456631846	0.748332502170859
Bisoprolol	Repaglinide	0.214	-1.21	Moderate	2 (1/1)		#B2D0E5	0.243272304421231	1
Acetaminophen	Warfarin	0.313	-1.089	Minor	38 (20/18)	Acetaminophen may increase the anticoagulant activities of Warfarin.	#B4D1E6	4.62217378400339	1
Salbutamol	Clomipramine	0.162	-1.296	Moderate	58 (28/30)	The risk or severity of adverse effects can be increased when Clomipramine is combined with Salbutamol.	#B1CFE5	7.05489682821569	1
Ethinylestradiol	Etoricoxib	0.182	Inf	None	41 (41/0)	Etoricoxib may increase the thrombogenic activities of Ethinyl Estradiol.	#B32020	4.98708224063523	1
Gemfibrozil	Acenocoumarol	0.289	-3.025	None	7 (2/5)	The metabolism of Acenocoumarol can be decreased when combined with Gemfibrozil.	#9CBFDB	0.851453065474308	0.241311116219756
Indomethacin	Alendronic acid	0.248	2.48	Moderate	4 (3/1)	The risk or severity of adverse effects can be increased when Indomethacin is combined with Alendronic acid.	#F0A9A9	0.486544608842462	1
Sumatriptan	Paroxetine	0.293	12.398	Major	32 (30/2)	The risk or severity of adverse effects can be increased when Sumatriptan is combined with Paroxetine.	#B72B2B	3.89235687073969	1
Eletriptan	Venlafaxine	0.235	Inf	Major	6 (6/0)	The serum concentration of Eletriptan can be increased when it is combined with Venlafaxine.	#B32020	0.729816913263693	1
Ciprofloxacin	Acenocoumarol	0.202	-1.423	None	37 (17/20)		#AFCEE4	4.50053763179277	1
Fluoxetine	Almotriptan	0.272	4.959	Major	21 (18/3)	The metabolism of Almotriptan can be decreased when combined with Fluoxetine.	#E28989	2.55435919642292	1
Tacrolimus	Nifedipine	0.376	-2.904	Moderate	17 (5/12)	The serum concentration of Tacrolimus can be increased when it is combined with Nifedipine.	#9DC0DC	2.06781458758046	4.96421353409002e-07
Erythromycin	Lincomycin	0.833	Inf	Moderate	3 (3/0)	The therapeutic efficacy of Erythromycin can be decreased when used in combination with Lincomycin.	#B32020	0.364908456631846	1
Fluvoxamine	Phenytoin	0.24	Inf	Moderate	1 (1/0)	The serum concentration of Phenytoin can be increased when it is combined with Fluvoxamine.	#B32020	0.121636152210615	1
Eletriptan	Escitalopram	0.271	7.439	Major	10 (9/1)	The risk or severity of adverse effects can be increased when Eletriptan is combined with Escitalopram.	#D46A6A	1.21636152210615	1
Lamotrigine	Ethinylestradiol	0.218	Inf	Moderate	36 (36/0)	The serum concentration of Lamotrigine can be decreased when it is combined with Ethinyl Estradiol.	#B32020	4.37890147958216	1
Fluoxetine	Carbamazepine	0.317	-1.861	Moderate	33 (13/20)	The metabolism of Carbamazepine can be decreased when combined with Fluoxetine.	#ABCBE2	4.01399302295031	1
Cyclosporine	Nifedipine	0.397	Inf	Moderate	2 (2/0)	The metabolism of Nifedipine can be decreased when combined with Cyclosporine.	#B32020	0.243272304421231	1
Fluoxetine	Doxepin	0.538	Inf	Major	2 (2/0)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Doxepin.	#B32020	0.243272304421231	1
Propranolol	Clonidine	0.533	-2.42	Major	3 (1/2)	Clonidine may increase the atrioventricular blocking (AV block) activities of Propranolol.	#A3C5DF	0.364908456631846	1
Omeprazole	Flurazepam	0.35	-1.291	Moderate	31 (15/16)		#B1CFE5	3.77072071852908	1
Piroxicam	Lithium cation	0.25	Inf	Major	1 (1/0)	The serum concentration of Lithium can be increased when it is combined with Piroxicam.	#B32020	0.121636152210615	1
Chlorpromazine	Propranolol	0.087	1.653	Moderate	3 (2/1)	The metabolism of Propranolol can be decreased when combined with Chlorpromazine.	#F5B4B4	0.364908456631846	1
Cyclosporine	Mefenamic acid	0.154	Inf	Moderate	1 (1/0)	Mefenamic acid may increase the nephrotoxic activities of Cyclosporine.	#B32020	0.121636152210615	1
Venlafaxine	Propafenone	0.067	Inf	Moderate	1 (1/0)	The serum concentration of Venlafaxine can be increased when it is combined with Propafenone.	#B32020	0.121636152210615	1
Irbesartan	Lithium cation	0.5	Inf	Moderate	1 (1/0)	The serum concentration of Lithium can be increased when it is combined with Irbesartan.	#B32020	0.121636152210615	1
Zolmitriptan	Dihydroergotamine	0.633	1.929	Major	10 (7/3)	Dihydroergotamine may increase the vasoconstricting activities of Zolmitriptan.	#F4B1B1	1.21636152210615	1
Zolmitriptan	Fluoxetine	0.339	6.888	Major	28 (25/3)	The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Fluoxetine.	#D77272	3.40581226189723	1
Carvedilol	Insulin aspart	0.268	-1.815	Moderate	5 (2/3)		#ABCBE2	0.608180761053077	1
Tacrolimus	Telithromycin	0.5	Inf	Major	1 (1/0)	The serum concentration of Tacrolimus can be increased when it is combined with Telithromycin.	#B32020	0.121636152210615	1
Fluconazole	Clonazepam	0.212	2.225	None	48 (35/13)	The metabolism of Clonazepam can be decreased when combined with Fluconazole.	#F2AEAE	5.83853530610954	1
Atenolol	Verapamil	0.778	-2.42	Major	3 (1/2)	Verapamil may increase the hypotensive activities of Atenolol.	#A3C5DF	0.364908456631846	1
Metoprolol	Ibuprofen	0.281	3.141	Moderate	24 (19/5)	Ibuprofen may decrease the antihypertensive activities of Metoprolol.	#EDA1A1	2.91926765305477	1
Moxifloxacin	Josamycin	0.917	Inf	None	6 (6/0)		#B32020	0.729816913263693	1
Paroxetine	Rasagiline	0.2	Inf	Major	1 (1/0)	The risk or severity of adverse effects can be increased when Paroxetine is combined with Rasagiline.	#B32020	0.121636152210615	1
Diclofenac	Lithium cation	0.096	1.267	Moderate	38 (23/15)	The serum concentration of Lithium can be increased when it is combined with Diclofenac.	#F7B9B9	4.62217378400339	1
Captopril	Lithium cation	0.111	Inf	Moderate	1 (1/0)	The serum concentration of Lithium can be increased when it is combined with Captopril.	#B32020	0.121636152210615	1
Citalopram	Eletriptan	0.409	8.265	Major	11 (10/1)	The risk or severity of adverse effects can be increased when Citalopram is combined with Eletriptan.	#CF5F5F	1.33799767431677	1
Haloperidol	Propranolol	0.19	-2.42	Moderate	12 (4/8)	The metabolism of Propranolol can be decreased when combined with Haloperidol.	#A3C5DF	1.45963382652739	0.698790919781634
Methylprednisolone	Clarithromycin	0.778	1.332	Major	47 (29/18)	The serum concentration of Methylprednisolone can be increased when it is combined with Clarithromycin.	#F7B9B9	5.71689915389893	1
Bisoprolol	Ergotamine	0.382	Inf	Moderate	4 (4/0)	Ergotamine may increase the atrioventricular blocking (AV block) activities of Bisoprolol.	#B32020	0.486544608842462	1
Phenytoin	Furosemide	1	Inf	Minor	1 (1/0)	Phenytoin may decrease the diuretic activities of Furosemide.	#B32020	0.121636152210615	1
Minocycline	Amoxicillin	0.417	1.221	Moderate	166 (99/67)	The therapeutic efficacy of Amoxicillin can be decreased when used in combination with Minocycline.	#F8BABA	20.1916012669622	1
Oxycodone	Sertraline	0.392	2.48	Moderate	4 (3/1)	The metabolism of Oxycodone can be decreased when combined with Sertraline.	#F0A9A9	0.486544608842462	1
Cyclosporine	Ibuprofen	0.218	1.198	Moderate	49 (29/20)	Ibuprofen may increase the nephrotoxic activities of Cyclosporine.	#F8BABA	5.96017145832016	1
Eletriptan	Ergotamine	0.434	2.48	Major	4 (3/1)	Ergotamine may increase the vasoconstricting activities of Eletriptan.	#F0A9A9	0.486544608842462	1
Carbamazepine	Verapamil	1	Inf	Major	1 (1/0)	The serum concentration of Carbamazepine can be increased when it is combined with Verapamil.	#B32020	0.121636152210615	1
Ciprofloxacin	Methotrexate	0.097	1.353	Moderate	29 (18/11)	The serum concentration of Methotrexate can be increased when it is combined with Ciprofloxacin.	#F7B9B9	3.52744841410785	1
Atenolol	Piroxicam	0.053	Inf	Moderate	1 (1/0)	Piroxicam may decrease the antihypertensive activities of Atenolol.	#B32020	0.121636152210615	1
Phenytoin	Gabapentin	0.558	-3.63	Moderate	8 (2/6)	The risk or severity of adverse effects can be increased when Gabapentin is combined with Phenytoin.	#94B9D8	0.973089217684923	0.144983334766465
Fluoxetine	Carvedilol	0.385	3.306	Moderate	5 (4/1)	The metabolism of Carvedilol can be decreased when combined with Fluoxetine.	#EC9F9F	0.608180761053077	1
Fluoxetine	Dextromethorphan	0.307	2.066	Major	63 (45/18)	Fluoxetine may increase the serotonergic activities of Dextromethorphan.	#F3AFAF	7.66307758926877	1
Citalopram	Almotriptan	0.353	3.513	Major	21 (17/4)	The risk or severity of adverse effects can be increased when Citalopram is combined with Almotriptan.	#EB9C9C	2.55435919642292	1
Fluoxetine	Acenocoumarol	0.218	2.204	None	11 (8/3)	The metabolism of Acenocoumarol can be decreased when combined with Fluoxetine.	#F2AEAE	1.33799767431677	1
Cyclosporine	Fluconazole	0.385	1.102	Moderate	14 (8/6)	The serum concentration of Cyclosporine can be increased when it is combined with Fluconazole.	#F9BCBC	1.70290613094862	1
Diazepam	Itraconazole	0.491	1.676	Moderate	109 (73/36)	The metabolism of Diazepam can be decreased when combined with Itraconazole.	#F5B4B4	13.2583405909571	1
Hydrocortisone	Acenocoumarol	0.411	-1.21	None	10 (5/5)		#B2D0E5	1.21636152210615	1
Dihydroergotamine	Rizatriptan	0.821	4.959	Major	7 (6/1)	Dihydroergotamine may increase the vasoconstricting activities of Rizatriptan.	#E28989	0.851453065474308	1
Raloxifene	Estradiol	0.1	Inf	Moderate	3 (3/0)		#B32020	0.364908456631846	1
Itraconazole	Budesonide	0.452	1.523	Major	108 (70/38)	The serum concentration of Budesonide can be increased when it is combined with Itraconazole.	#F6B6B6	13.1367044387465	1
Phenytoin	Dexamethasone	0.516	-8.469	Moderate	8 (1/7)	The serum concentration of Dexamethasone can be decreased when it is combined with Phenytoin.	#598DBE	0.973089217684923	1.06963870880566e-05
Lorazepam	Phenytoin	0.395	-1.21	Moderate	10 (5/5)	The serum concentration of Phenytoin can be increased when it is combined with Lorazepam.	#B2D0E5	1.21636152210615	1
Bisoprolol	Salbutamol	0.265	-1.337	Moderate	40 (19/21)	Bisoprolol may decrease the bronchodilatory activities of Salbutamol.	#B1CFE5	4.86544608842462	1
Alendronic acid	Ketoprofen	0.2	Inf	Moderate	1 (1/0)	The risk or severity of adverse effects can be increased when Ketoprofen is combined with Alendronic acid.	#B32020	0.121636152210615	1
Fluconazole	Amitriptyline	0.446	3.389	Moderate	51 (41/10)	Amitriptyline may increase the QTc-prolonging activities of Fluconazole.	#EB9E9E	6.20344376274139	1
Duloxetine	Ciprofloxacin	0.197	2.296	Major	34 (25/9)		#F2ACAC	4.13562917516092	1
Spironolactone	Lisinopril	0.537	-1.21	Major	2 (1/1)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Lisinopril.	#B2D0E5	0.243272304421231	1
Ciprofloxacin	Sevelamer	0.478	-1.21	Moderate	6 (3/3)		#B2D0E5	0.729816913263693	1
Eletriptan	Sertraline	0.315	Inf	Major	6 (6/0)	The risk or severity of adverse effects can be increased when Eletriptan is combined with Sertraline.	#B32020	0.729816913263693	1
Rifampicin	Leflunomide	0.4	Inf	Major	1 (1/0)	The serum concentration of the active metabolites of Leflunomide can be increased when Leflunomide is used in combination with Rifampicin.	#B32020	0.121636152210615	1
Piroxicam	Methotrexate	0.158	Inf	Major	1 (1/0)	The serum concentration of Methotrexate can be increased when it is combined with Piroxicam.	#B32020	0.121636152210615	1
Doxycycline	Phenobarbital	0.116	1.102	Moderate	7 (4/3)	The serum concentration of Doxycycline can be decreased when it is combined with Phenobarbital.	#F9BCBC	0.851453065474308	1
Naproxen	Lithium cation	0.105	-1.019	Major	35 (19/16)	The serum concentration of Lithium can be increased when it is combined with Naproxen.	#B4D1E6	4.25726532737154	1
Labetalol	Ibuprofen	0.371	36.368	Moderate	45 (44/1)	Ibuprofen may decrease the antihypertensive activities of Labetalol.	#B32020	5.47362684947769	1
Warfarin	Acetylsalicylic acid	0.365	-1.815	Major	5 (2/3)	Acetylsalicylic acid may increase the anticoagulant activities of Warfarin.	#ABCBE2	0.608180761053077	1
Levofloxacin	Methotrimeprazine	0.072	-2.178	Moderate	14 (5/9)	Methotrimeprazine may increase the QTc-prolonging activities of Levofloxacin.	#A6C7E0	1.70290613094862	1
Oxycodone	Escitalopram	0.431	-1.21	Moderate	6 (3/3)	Oxycodone may increase the serotonergic activities of Escitalopram.	#B2D0E5	0.729816913263693	1
Alendronic acid	Ibuprofen	0.302	1.417	Moderate	38 (24/14)	The risk or severity of adverse effects can be increased when Ibuprofen is combined with Alendronic acid.	#F7B7B7	4.62217378400339	1
Phenobarbital	Acenocoumarol	0.59	-1.21	None	2 (1/1)	The metabolism of Acenocoumarol can be increased when combined with Phenobarbital.	#B2D0E5	0.243272304421231	1
Amitriptyline	Clonidine	0.169	-1.21	Major	2 (1/1)	Amitriptyline may decrease the antihypertensive activities of Clonidine.	#B2D0E5	0.243272304421231	1
Ergotamine	Frovatriptan	0.611	1.653	Major	3 (2/1)	Ergotamine may increase the vasoconstricting activities of Frovatriptan.	#F5B4B4	0.364908456631846	1
Folic acid	Phenobarbital	0.196	-1.037	Moderate	13 (7/6)	The serum concentration of Phenobarbital can be decreased when it is combined with Folic Acid.	#B4D1E6	1.581269978738	1
Citalopram	Carvedilol	0.423	3.306	Moderate	5 (4/1)	The metabolism of Carvedilol can be decreased when combined with Citalopram.	#EC9F9F	0.608180761053077	1
Citalopram	Moclobemide	0.222	-1.21	None	2 (1/1)	The serum concentration of Citalopram can be increased when it is combined with Moclobemide.	#B2D0E5	0.243272304421231	1
Doxycycline	Isotretinoin	0.403	8.265	Major	11 (10/1)	The risk or severity of adverse effects can be increased when Doxycycline is combined with Isotretinoin.	#CF5F5F	1.33799767431677	1
Pimozide	Escitalopram	0.161	-3.025	Major	7 (2/5)	The risk or severity of QTc prolongation can be increased when Pimozide is combined with Escitalopram.	#9CBFDB	0.851453065474308	1
Paroxetine	Carvedilol	0.286	-1.815	Moderate	10 (4/6)	The metabolism of Carvedilol can be decreased when combined with Paroxetine.	#ABCBE2	1.21636152210615	1
Paroxetine	Acenocoumarol	0.327	1.653	None	12 (8/4)	Paroxetine may increase the anticoagulant activities of Acenocoumarol.	#F5B4B4	1.45963382652739	1
Paroxetine	Moclobemide	0.583	-1.21	None	2 (1/1)	The risk or severity of adverse effects can be increased when Paroxetine is combined with Moclobemide.	#B2D0E5	0.243272304421231	1
Fluvoxamine	Carbamazepine	0.285	-2.42	Moderate	6 (2/4)	The metabolism of Carbamazepine can be decreased when combined with Fluvoxamine.	#A3C5DF	0.729816913263693	1
Acetylsalicylic acid	Ginkgo biloba	0.585	2.48	Moderate	4 (3/1)	Ginkgo biloba may increase the anticoagulant activities of Acetylsalicylic acid.	#F0A9A9	0.486544608842462	1
Torasemide	Ibuprofen	0.333	1.188	Moderate	39 (23/16)	The therapeutic efficacy of Torasemide can be decreased when used in combination with Ibuprofen.	#F8BABA	4.743809936214	1
Fluvoxamine	Rizatriptan	0.092	Inf	Major	4 (4/0)	The metabolism of Rizatriptan can be decreased when combined with Fluvoxamine.	#B32020	0.486544608842462	1
Erythromycin	Methylprednisolone	0.751	2.755	Moderate	13 (10/3)	The metabolism of Methylprednisolone can be decreased when combined with Erythromycin.	#EFA6A6	1.581269978738	1
Erythromycin	Diazepam	0.408	2.539	Moderate	57 (43/14)	The metabolism of Diazepam can be decreased when combined with Erythromycin.	#F0A9A9	6.93326067600508	1
Citalopram	Warfarin	0.221	Inf	Moderate	3 (3/0)	The metabolism of Warfarin can be decreased when combined with Citalopram.	#B32020	0.364908456631846	1
Fenofibrate	Acenocoumarol	0.042	Inf	None	1 (1/0)	Fenofibrate may increase the anticoagulant activities of Acenocoumarol.	#B32020	0.121636152210615	1
Imipramine	Carbamazepine	0.464	-1.21	Moderate	2 (1/1)	The metabolism of Imipramine can be increased when combined with Carbamazepine.	#B2D0E5	0.243272304421231	1
Naproxen	Acenocoumarol	0.307	3.306	None	20 (16/4)	Naproxen may increase the anticoagulant activities of Acenocoumarol.	#EC9F9F	2.43272304421231	1
Triamcinolone	Phenobarbital	0.038	1.653	Moderate	3 (2/1)	The metabolism of Triamcinolone can be increased when combined with Phenobarbital.	#F5B4B4	0.364908456631846	1
Medroxyprogesterone acetate	Phenobarbital	0.197	Inf	Moderate	3 (3/0)	The metabolism of Medroxyprogesterone acetate can be increased when combined with Phenobarbital.	#B32020	0.364908456631846	1
Valproic acid	Nimodipine	0.222	-1.21	Minor	2 (1/1)		#B2D0E5	0.243272304421231	1
Eletriptan	Fluoxetine	0.132	Inf	Major	6 (6/0)	The metabolism of Eletriptan can be decreased when combined with Fluoxetine.	#B32020	0.729816913263693	1
Sucralfate	Levofloxacin	0.61	Inf	Moderate	6 (6/0)	The serum concentration of Levofloxacin can be decreased when it is combined with Sucralfate.	#B32020	0.729816913263693	1
Erythromycin	Sertraline	0.24	3.857	Moderate	17 (14/3)	The risk or severity of adverse effects can be increased when Erythromycin is combined with Sertraline.	#E89898	2.06781458758046	1
Atorvastatin	Itraconazole	0.227	1.929	Major	10 (7/3)	The risk or severity of adverse effects can be increased when Itraconazole is combined with Atorvastatin.	#F4B1B1	1.21636152210615	1
Risperidone	Itraconazole	0.227	1.653	None	12 (8/4)	The metabolism of Risperidone can be decreased when combined with Itraconazole.	#F5B4B4	1.45963382652739	1
Propranolol	Salbutamol	0.333	2.404	Major	43 (32/11)		#F1ABAB	5.23035454505646	1
Cyproheptadine	Fluoxetine	0.545	Inf	Moderate	2 (2/0)	The therapeutic efficacy of Fluoxetine can be decreased when used in combination with Cyproheptadine.	#B32020	0.243272304421231	1
Dihydroergotamine	Atenolol	0.571	Inf	Moderate	2 (2/0)	Dihydroergotamine may increase the atrioventricular blocking (AV block) activities of Atenolol.	#B32020	0.243272304421231	1
Propranolol	Formoterol	0.358	3.719	Major	22 (18/4)		#E99999	2.67599534863354	1
Salmeterol	Carvedilol	0.281	Inf	Major	2 (2/0)	Carvedilol may decrease the vasoconstricting activities of Salmeterol.	#B32020	0.243272304421231	1
Fluconazole	Carbamazepine	0.127	1.515	Moderate	17 (11/6)	The serum concentration of Carbamazepine can be increased when it is combined with Fluconazole.	#F6B6B6	2.06781458758046	1
Erythromycin	Alprazolam	0.32	1.459	Moderate	47 (30/17)	The serum concentration of Alprazolam can be increased when it is combined with Erythromycin.	#F7B7B7	5.71689915389893	1
Fluvoxamine	Mirtazapine	0.548	-3.63	Major	12 (3/9)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Mirtazapine.	#94B9D8	1.45963382652739	0.946375606319376
Omeprazole	Ketoconazole	0.606	1.358	Moderate	37 (23/14)	The serum concentration of Ketoconazole can be decreased when it is combined with Omeprazole.	#F7B9B9	4.50053763179277	1
Phenobarbital	Dexamethasone	0.03	-1.21	Moderate	2 (1/1)	The serum concentration of Dexamethasone can be decreased when it is combined with Phenobarbital.	#B2D0E5	0.243272304421231	1
Cyclosporine	Ciprofloxacin	0.181	-1.556	Moderate	16 (7/9)		#AECDE3	1.94617843536985	1
Alendronic acid	Naproxen	0.309	8.265	Moderate	11 (10/1)	The risk or severity of adverse effects can be increased when Naproxen is combined with Alendronic acid.	#CF5F5F	1.33799767431677	1
Citalopram	Oxycodone	0.321	-1.21	Moderate	6 (3/3)	The metabolism of Oxycodone can be decreased when combined with Citalopram.	#B2D0E5	0.729816913263693	1
Erythromycin	Moxifloxacin	0.756	1.86	Major	13 (9/4)	Erythromycin may increase the QTc-prolonging activities of Moxifloxacin.	#F5B2B2	1.581269978738	1
Fluoxetine	Ergotamine	0.191	7.439	Major	10 (9/1)	The risk or severity of adverse effects can be increased when Ergotamine is combined with Fluoxetine.	#D46A6A	1.21636152210615	1
Erythromycin	Citalopram	0.202	3.926	Major	23 (19/4)	The metabolism of Citalopram can be decreased when combined with Erythromycin.	#E89898	2.79763150084416	1
Metronidazole	Acenocoumarol	0.255	1.653	None	9 (6/3)	The serum concentration of Acenocoumarol can be increased when it is combined with Metronidazole.	#F5B4B4	1.09472536989554	1
Carbamazepine	Bupropion	0.311	1.653	Moderate	3 (2/1)	The metabolism of Bupropion can be increased when combined with Carbamazepine.	#F5B4B4	0.364908456631846	1
Clozapine	Bromazepam	0.4	Inf	None	1 (1/0)	The risk or severity of adverse effects can be increased when Bromazepam is combined with Clozapine.	#B32020	0.121636152210615	1
Nabumetone	Methotrexate	0.091	Inf	Major	1 (1/0)	The serum concentration of Methotrexate can be increased when it is combined with Nabumetone.	#B32020	0.121636152210615	1
Fluvoxamine	Frovatriptan	1	Inf	Major	1 (1/0)	The metabolism of Frovatriptan can be decreased when combined with Fluvoxamine.	#B32020	0.121636152210615	1
Atenolol	Salbutamol	0.313	-1.396	Moderate	28 (13/15)	Atenolol may decrease the bronchodilatory activities of Salbutamol.	#AFCEE4	3.40581226189723	1
Diltiazem	Tacrolimus	0.143	Inf	Moderate	1 (1/0)	The metabolism of Tacrolimus can be decreased when combined with Diltiazem.	#B32020	0.121636152210615	1
Acetylsalicylic acid	Insulin detemir	0.538	-1.21	Moderate	6 (3/3)	Acetylsalicylic acid may increase the hypoglycemic activities of Insulin Detemir.	#B2D0E5	0.729816913263693	1
Carbamazepine	Clarithromycin	0.182	1.136	Major	19 (11/8)	The serum concentration of the active metabolites of Clarithromycin can be increased when Clarithromycin is used in combination with Carbamazepine.	#F8BABA	2.31108689200169	1
Ciprofloxacin	Iron	0.585	8.147	Moderate	76 (69/7)		#D06060	9.24434756800677	1
Warfarin	Ibuprofen	0.314	1.01	Major	20 (11/9)	Ibuprofen may increase the anticoagulant activities of Warfarin.	#F9BCBC	2.43272304421231	1
Theophylline	Carbamazepine	0.375	-1.21	Moderate	2 (1/1)	The serum concentration of Theophylline can be decreased when it is combined with Carbamazepine.	#B2D0E5	0.243272304421231	1
Ziprasidone	Carbamazepine	0.498	-8.469	Minor	8 (1/7)	The serum concentration of Ziprasidone can be decreased when it is combined with Carbamazepine.	#598DBE	0.973089217684923	0.00057050712300066
Fluconazole	Simvastatin	0.267	3.1	Major	19 (15/4)	The serum concentration of Simvastatin can be increased when it is combined with Fluconazole.	#EDA1A1	2.31108689200169	1
Phenytoin	Medroxyprogesterone acetate	0.4	Inf	Moderate	2 (2/0)	The therapeutic efficacy of Medroxyprogesterone acetate can be decreased when used in combination with Phenytoin.	#B32020	0.243272304421231	1
Valsartan	Lithium cation	0.052	-1.21	Moderate	2 (1/1)	The serum concentration of Lithium can be increased when it is combined with Valsartan.	#B2D0E5	0.243272304421231	1
Phenytoin	Prednisone	0.251	1.102	Moderate	7 (4/3)	The serum concentration of Prednisone can be decreased when it is combined with Phenytoin.	#F9BCBC	0.851453065474308	1
Citalopram	Frovatriptan	0.397	Inf	Major	5 (5/0)	The risk or severity of adverse effects can be increased when Citalopram is combined with Frovatriptan.	#B32020	0.608180761053077	1
Glimepiride	Pregabalin	0.1	Inf	None	1 (1/0)	The risk or severity of heart failure can be increased when Pregabalin is combined with Glimepiride.	#B32020	0.121636152210615	1
Paroxetine	Almotriptan	0.256	4.959	Major	14 (12/2)	The metabolism of Almotriptan can be decreased when combined with Paroxetine.	#E28989	1.70290613094862	1
Azithromycin	Acenocoumarol	0.175	-1.109	None	23 (12/11)	The metabolism of Acenocoumarol can be decreased when combined with Azithromycin.	#B4D1E6	2.79763150084416	1
Oxcarbazepine	Ethinylestradiol	0.254	Inf	Major	16 (16/0)	The serum concentration of Ethinyl Estradiol can be decreased when it is combined with Oxcarbazepine.	#B32020	1.94617843536985	1
Erythromycin	Levofloxacin	0.758	1.343	Moderate	21 (13/8)	Erythromycin may increase the QTc-prolonging activities of Levofloxacin.	#F7B9B9	2.55435919642292	1
Prednisone	Rifampicin	0.451	-1.748	Moderate	22 (9/13)	The serum concentration of Prednisone can be decreased when it is combined with Rifampicin.	#ABCBE2	2.67599534863354	1
Citalopram	Pimozide	0.532	-2.42	Major	6 (2/4)	The risk or severity of QTc prolongation can be increased when Citalopram is combined with Pimozide.	#A3C5DF	0.729816913263693	1
Alprazolam	Josamycin	0.191	9.918	None	13 (12/1)	The serum concentration of Alprazolam can be increased when it is combined with Josamycin.	#C64A4A	1.581269978738	1
Ibuprofen	Carvedilol	0.198	-1.582	Moderate	30 (13/17)	Ibuprofen may decrease the antihypertensive activities of Carvedilol.	#AECDE3	3.64908456631846	1
Doxycycline	Insulin aspart	0.072	-1.479	Moderate	20 (9/11)		#AFCEE4	2.43272304421231	1
Doxycycline	Rifampicin	0.643	-1.21	Moderate	10 (5/5)	The serum concentration of Doxycycline can be decreased when it is combined with Rifampicin.	#B2D0E5	1.21636152210615	1
Metoprolol	Epinephrine	0.5	Inf	Moderate	1 (1/0)	Epinephrine may increase the atrioventricular blocking (AV block) activities of Metoprolol.	#B32020	0.121636152210615	1
Erythromycin	Theophylline	0.279	Inf	Moderate	2 (2/0)	The metabolism of Theophylline can be decreased when combined with Erythromycin.	#B32020	0.243272304421231	1
Propranolol	Salmeterol	0.242	2.755	Major	13 (10/3)		#EFA6A6	1.581269978738	1
Omeprazole	Triazolam	0.613	3.306	Moderate	5 (4/1)		#EC9F9F	0.608180761053077	1
Clonazepam	Itraconazole	0.313	2.149	None	18 (13/5)	The metabolism of Clonazepam can be decreased when combined with Itraconazole.	#F2AEAE	2.18945073979108	1
Doxycycline	Cloxacillin	0.746	-1.43	Moderate	48 (22/26)	The therapeutic efficacy of Cloxacillin can be decreased when used in combination with Doxycycline.	#AFCEE4	5.83853530610954	1
Losartan	Lithium cation	0.435	-2.42	Moderate	3 (1/2)	The serum concentration of Lithium can be increased when it is combined with Losartan.	#A3C5DF	0.364908456631846	1
Methotrexate	Mefenamic acid	0.143	Inf	Major	1 (1/0)	The serum concentration of Methotrexate can be increased when it is combined with Mefenamic acid.	#B32020	0.121636152210615	1
Prednisone	Itraconazole	0.56	1.392	Moderate	51 (32/19)	The serum concentration of Prednisone can be increased when it is combined with Itraconazole.	#F7B7B7	6.20344376274139	1
Citalopram	Acenocoumarol	0.254	-1.21	None	12 (6/6)	The metabolism of Acenocoumarol can be decreased when combined with Citalopram.	#B2D0E5	1.45963382652739	1
Dihydroergotamine	Fluoxetine	0.303	2.48	Major	8 (6/2)	The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Fluoxetine.	#F0A9A9	0.973089217684923	1
Carbamazepine	Metronidazole	0.189	1.929	Moderate	10 (7/3)	The metabolism of Metronidazole can be increased when combined with Carbamazepine.	#F4B1B1	1.21636152210615	1
Doxycycline	Methotrexate	0.335	1.653	Moderate	9 (6/3)		#F5B4B4	1.09472536989554	1
Carbamazepine	Itraconazole	0.437	2.48	Moderate	8 (6/2)	The serum concentration of Itraconazole can be decreased when it is combined with Carbamazepine.	#F0A9A9	0.973089217684923	1
Terbutaline	Carvedilol	0.194	1.653	Major	3 (2/1)	Carvedilol may decrease the vasoconstricting activities of Terbutaline.	#F5B4B4	0.364908456631846	1
Phenytoin	Alprazolam	0.248	-1.21	Moderate	8 (4/4)	The serum concentration of Phenytoin can be increased when it is combined with Alprazolam.	#B2D0E5	0.973089217684923	1
Almotriptan	Itraconazole	0.39	Inf	Moderate	8 (8/0)	The serum concentration of Almotriptan can be increased when it is combined with Itraconazole.	#B32020	0.973089217684923	1
Gentamicin	Cefuroxime	0.875	-1.21	Moderate	4 (2/2)		#B2D0E5	0.486544608842462	1
Rifabutin	Clarithromycin	0.342	-1.21	Moderate	2 (1/1)	The serum concentration of the active metabolites of Clarithromycin can be increased when Clarithromycin is used in combination with Rifabutin.	#B2D0E5	0.243272304421231	1
Citalopram	Josamycin	0.288	2.893	None	9 (7/2)		#EEA4A4	1.09472536989554	1
Carbamazepine	Norethisterone	0.607	Inf	Major	2 (2/0)	The metabolism of Norethisterone can be increased when combined with Carbamazepine.	#B32020	0.243272304421231	1
Metronidazole	Phenobarbital	0.142	1.24	Moderate	5 (3/2)	The serum concentration of Metronidazole can be decreased when it is combined with Phenobarbital.	#F8BABA	0.608180761053077	1
Levofloxacin	Josamycin	0.556	4.133	None	6 (5/1)		#E79494	0.729816913263693	1
Almotriptan	Sertraline	0.238	5.786	Major	8 (7/1)	The risk or severity of adverse effects can be increased when Almotriptan is combined with Sertraline.	#DE8080	0.973089217684923	1
Phenytoin	Quetiapine	0.474	-9.679	Major	9 (1/8)	The serum concentration of Quetiapine can be decreased when it is combined with Phenytoin.	#4A82B8	1.09472536989554	0.00622616902100118
Enalapril	Drospirenone	0.193	Inf	Moderate	11 (11/0)	Enalapril may increase the hyperkalemic activities of Drospirenone.	#B32020	1.33799767431677	1
Amitriptyline	Epinephrine	0.258	6.612	Major	9 (8/1)	Amitriptyline may decrease the antihypertensive activities of Epinephrine.	#D97575	1.09472536989554	1
Acetylsalicylic acid	Dexamethasone	0.636	1.102	Moderate	7 (4/3)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Dexamethasone.	#F9BCBC	0.851453065474308	1
Indomethacin	Carvedilol	0.563	-2.42	Moderate	3 (1/2)	Indomethacin may decrease the antihypertensive activities of Carvedilol.	#A3C5DF	0.364908456631846	1
Fluconazole	Fentanyl	0.265	-1.21	Major	8 (4/4)	The serum concentration of Fentanyl can be increased when it is combined with Fluconazole.	#B2D0E5	0.973089217684923	1
Doxycycline	Iron	0.62	25.623	Moderate	32 (31/1)	Doxycycline can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B32020	3.89235687073969	1
Erythromycin	Fluoxetine	0.309	3.582	Moderate	16 (13/3)	The metabolism of Fluoxetine can be decreased when combined with Erythromycin.	#EB9C9C	1.94617843536985	1
Prednisone	Warfarin	0.341	1.24	Moderate	5 (3/2)	Prednisone may increase the anticoagulant activities of Warfarin.	#F8BABA	0.608180761053077	1
Itraconazole	Clarithromycin	0.713	1.535	Moderate	40 (26/14)	The metabolism of Clarithromycin can be decreased when combined with Itraconazole.	#F6B6B6	4.86544608842462	1
Betamethasone	Acetylsalicylic acid	0.5	Inf	Moderate	3 (3/0)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Betamethasone.	#B32020	0.364908456631846	1
Modafinil	Ethinylestradiol	0.327	Inf	Moderate	4 (4/0)	The serum concentration of Ethinyl Estradiol can be decreased when it is combined with Modafinil.	#B32020	0.486544608842462	1
Ranitidine	Itraconazole	0.598	2.02	Moderate	31 (22/9)	The serum concentration of Itraconazole can be decreased when it is combined with Ranitidine.	#F3AFAF	3.77072071852908	1
Cloxacillin	Acenocoumarol	0.093	-1.936	None	13 (5/8)	Cloxacillin may decrease the anticoagulant activities of Acenocoumarol.	#A9C9E1	1.581269978738	1
Indomethacin	Nadolol	0.208	Inf	Moderate	2 (2/0)	Indomethacin may decrease the antihypertensive activities of Nadolol.	#B32020	0.243272304421231	1
Bisoprolol	Salmeterol	0.35	-1.21	Moderate	8 (4/4)	Bisoprolol may decrease the bronchodilatory activities of Salmeterol.	#B2D0E5	0.973089217684923	1
Phenytoin	Trimethoprim	0.206	-1.21	Moderate	2 (1/1)	The serum concentration of Phenytoin can be increased when it is combined with Trimethoprim.	#B2D0E5	0.243272304421231	1
Fluconazole	Atorvastatin	0.215	3.306	Major	10 (8/2)	The serum concentration of Atorvastatin can be increased when it is combined with Fluconazole.	#EC9F9F	1.21636152210615	1
Moxifloxacin	Warfarin	0.029	Inf	Major	1 (1/0)		#B32020	0.121636152210615	1
Eletriptan	Itraconazole	0.424	Inf	Major	4 (4/0)	The serum concentration of Eletriptan can be increased when it is combined with Itraconazole.	#B32020	0.486544608842462	1
Phenytoin	Fluoxetine	0.356	-2.42	Moderate	6 (2/4)	The serum concentration of Phenytoin can be increased when it is combined with Fluoxetine.	#A3C5DF	0.729816913263693	1
Cyclosporine	Azithromycin	0.197	-1.037	Moderate	13 (7/6)	The metabolism of Cyclosporine can be decreased when combined with Azithromycin.	#B4D1E6	1.581269978738	1
Ampicillin	Tetracycline	1	Inf	Moderate	1 (1/0)		#B32020	0.121636152210615	1
Isotretinoin	Minocycline	0.394	Inf	Major	4 (4/0)	The risk or severity of adverse effects can be increased when Minocycline is combined with Isotretinoin.	#B32020	0.486544608842462	1
Clozapine	Diazepam	0.301	-10.082	Major	28 (3/25)	The risk or severity of adverse effects can be increased when Diazepam is combined with Clozapine.	#457EB6	3.40581226189723	0.361944455390868
Prednisone	Primidone	0.136	Inf	Moderate	1 (1/0)	The serum concentration of Prednisone can be decreased when it is combined with Primidone.	#B32020	0.121636152210615	1
Pentoxifylline	Acenocoumarol	0.092	-1.21	None	2 (1/1)	Pentoxifylline may increase the anticoagulant activities of Acenocoumarol.	#B2D0E5	0.243272304421231	1
Levothyroxine	Cholestyramine	0.265	3.306	Moderate	5 (4/1)	The serum concentration of Levothyroxine can be decreased when it is combined with Cholestyramine.	#EC9F9F	0.608180761053077	1
Venlafaxine	Frovatriptan	0.065	Inf	Major	2 (2/0)	The risk or severity of adverse effects can be increased when Venlafaxine is combined with Frovatriptan.	#B32020	0.243272304421231	1
Carvedilol	Escitalopram	0.335	-3.63	None	8 (2/6)		#94B9D8	0.973089217684923	1
Fluconazole	Acenocoumarol	0.191	4.959	None	7 (6/1)	The serum concentration of Acenocoumarol can be increased when it is combined with Fluconazole.	#E28989	0.851453065474308	1
Disulfiram	Isoniazid	0.225	-1.21	Moderate	2 (1/1)	The risk or severity of adverse effects can be increased when Disulfiram is combined with Isoniazid.	#B2D0E5	0.243272304421231	1
Simvastatin	Clarithromycin	0.347	-1.412	Major	26 (12/14)	The serum concentration of Simvastatin can be increased when it is combined with Clarithromycin.	#AFCEE4	3.162539957476	1
Bisoprolol	Formoterol	0.317	-1.21	Moderate	12 (6/6)	Bisoprolol may decrease the bronchodilatory activities of Formoterol.	#B2D0E5	1.45963382652739	1
Cyclosporine	Metoclopramide	0.294	1.653	Moderate	9 (6/3)	Metoclopramide can cause an increase in the absorption of Cyclosporine resulting in an increased serum concentration and potentially a worsening of adverse effects.	#F5B4B4	1.09472536989554	1
Methotrexate	Cholestyramine	0.164	-3.63	None	4 (1/3)	Cholestyramine can cause a decrease in the absorption of Methotrexate resulting in a reduced serum concentration and potentially a decrease in efficacy.	#94B9D8	0.486544608842462	1
Cyclosporine	Fluoxetine	0.4	1.24	Moderate	5 (3/2)	The metabolism of Fluoxetine can be decreased when combined with Cyclosporine.	#F8BABA	0.608180761053077	1
Indomethacin	Propranolol	0.34	4.133	Moderate	6 (5/1)	Indomethacin may decrease the antihypertensive activities of Propranolol.	#E79494	0.729816913263693	1
Levonorgestrel	Phenobarbital	0.361	Inf	Major	5 (5/0)	The metabolism of Levonorgestrel can be increased when combined with Phenobarbital.	#B32020	0.608180761053077	1
Warfarin	Paroxetine	0.36	-1.21	Moderate	4 (2/2)	Paroxetine may increase the anticoagulant activities of Warfarin.	#B2D0E5	0.486544608842462	1
Doxycycline	Carbamazepine	0.257	-1.21	Moderate	10 (5/5)	The serum concentration of Doxycycline can be decreased when it is combined with Carbamazepine.	#B2D0E5	1.21636152210615	1
Acetylsalicylic acid	Insulin glulisine	0.23	-3.025	Moderate	7 (2/5)	Acetylsalicylic acid may increase the hypoglycemic activities of Insulin Glulisine.	#9CBFDB	0.851453065474308	1
Fluconazole	Tacrolimus	0.379	1.181	Major	17 (10/7)	The serum concentration of Tacrolimus can be increased when it is combined with Fluconazole.	#F8BABA	2.06781458758046	1
Phenytoin	Methylprednisolone	1	Inf	Moderate	1 (1/0)	The serum concentration of Methylprednisolone can be decreased when it is combined with Phenytoin.	#B32020	0.121636152210615	1
Dihydroergotamine	Almotriptan	1	Inf	Major	2 (2/0)	Dihydroergotamine may increase the vasoconstricting activities of Almotriptan.	#B32020	0.243272304421231	1
Simvastatin	Itraconazole	0.412	1.157	Major	12 (7/5)	The serum concentration of Simvastatin can be increased when it is combined with Itraconazole.	#F8BABA	1.45963382652739	1
Cyclosporine	Ethinylestradiol	0.122	Inf	Moderate	7 (7/0)	The metabolism of Ethinyl Estradiol can be decreased when combined with Cyclosporine.	#B32020	0.851453065474308	1
Folic acid	Phenytoin	0.419	-2.016	Moderate	8 (3/5)	The serum concentration of Phenytoin can be decreased when it is combined with Folic Acid.	#A8C8E1	0.973089217684923	1
Lidocaine	Atenolol	1	Inf	Moderate	1 (1/0)	The serum concentration of Lidocaine can be increased when it is combined with Atenolol.	#B32020	0.121636152210615	1
Metoprolol	Paroxetine	0.667	Inf	Moderate	2 (2/0)	The serum concentration of Metoprolol can be increased when it is combined with Paroxetine.	#B32020	0.243272304421231	1
Diclofenac	Warfarin	0.145	3.306	Major	5 (4/1)	Diclofenac may increase the anticoagulant activities of Warfarin.	#EC9F9F	0.608180761053077	1
Ciprofloxacin	Tizanidine	0.491	-1.037	Major	26 (14/12)	Tizanidine may increase the QTc-prolonging activities of Ciprofloxacin.	#B4D1E6	3.162539957476	1
Pantoprazole	Ketoconazole	0.575	1.24	Moderate	5 (3/2)	The serum concentration of Ketoconazole can be decreased when it is combined with Pantoprazole.	#F8BABA	0.608180761053077	1
Hydrocortisone	Acetylsalicylic acid	0.352	-1.21	Moderate	14 (7/7)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Hydrocortisone.	#B2D0E5	1.70290613094862	1
Pyridostigmine	Hydrocortisone	0.1	Inf	Moderate	1 (1/0)	The risk or severity of adverse effects can be increased when Hydrocortisone is combined with Pyridostigmine.	#B32020	0.121636152210615	1
Tacrolimus	Itraconazole	0.784	1.653	Major	9 (6/3)	The serum concentration of Tacrolimus can be increased when it is combined with Itraconazole.	#F5B4B4	1.09472536989554	1
Griseofulvin	Medroxyprogesterone acetate	0.143	Inf	Major	1 (1/0)	The serum concentration of Medroxyprogesterone acetate can be decreased when it is combined with Griseofulvin.	#B32020	0.121636152210615	1
Eprosartan	Drospirenone	0.143	Inf	Moderate	1 (1/0)	Eprosartan may increase the hyperkalemic activities of Drospirenone.	#B32020	0.121636152210615	1
Itraconazole	Phenobarbital	0.149	-1.21	Moderate	4 (2/2)	The serum concentration of Itraconazole can be decreased when it is combined with Phenobarbital.	#B2D0E5	0.486544608842462	1
Levonorgestrel	Carbamazepine	0.233	Inf	Major	10 (10/0)	The therapeutic efficacy of Levonorgestrel can be decreased when used in combination with Carbamazepine.	#B32020	1.21636152210615	1
Chlorpromazine	Levofloxacin	0.254	-3.63	Moderate	4 (1/3)	Chlorpromazine may increase the QTc-prolonging activities of Levofloxacin.	#94B9D8	0.486544608842462	1
Rabeprazole	Itraconazole	0.485	2.48	Moderate	8 (6/2)	The serum concentration of Itraconazole can be decreased when it is combined with Rabeprazole.	#F0A9A9	0.973089217684923	1
Phenytoin	Estradiol	0.363	Inf	Moderate	2 (2/0)	The therapeutic efficacy of Estradiol can be decreased when used in combination with Phenytoin.	#B32020	0.243272304421231	1
Carbamazepine	Ethinylestradiol	0.237	Inf	Major	12 (12/0)	The therapeutic efficacy of Ethinyl Estradiol can be decreased when used in combination with Carbamazepine.	#B32020	1.45963382652739	1
Lidocaine	Bisoprolol	0.875	-1.21	Moderate	2 (1/1)	The serum concentration of Lidocaine can be increased when it is combined with Bisoprolol.	#B2D0E5	0.243272304421231	1
Theophylline	Clarithromycin	0.833	2.48	Moderate	4 (3/1)	The metabolism of Theophylline can be decreased when combined with Clarithromycin.	#F0A9A9	0.486544608842462	1
Formoterol	Nadolol	0.174	Inf	Major	4 (4/0)		#B32020	0.486544608842462	1
Alprazolam	Ketoconazole	0.294	Inf	Major	8 (8/0)	The serum concentration of Alprazolam can be increased when it is combined with Ketoconazole.	#B32020	0.973089217684923	1
Ethinylestradiol	Rifampicin	0.158	Inf	Major	9 (9/0)	The metabolism of Ethinyl Estradiol can be increased when combined with Rifampicin.	#B32020	1.09472536989554	1
Simvastatin	Ketoconazole	0.265	Inf	Major	2 (2/0)	The serum concentration of Simvastatin can be increased when it is combined with Ketoconazole.	#B32020	0.243272304421231	1
Phenytoin	Hydrocortisone	0.402	-1.21	Moderate	2 (1/1)	The serum concentration of Hydrocortisone can be decreased when it is combined with Phenytoin.	#B2D0E5	0.243272304421231	1
Methylprednisolone	Rifampicin	0.269	1.653	Moderate	3 (2/1)	The serum concentration of Methylprednisolone can be decreased when it is combined with Rifampicin.	#F5B4B4	0.364908456631846	1
Erythromycin	Itraconazole	0.698	-1.075	Major	17 (9/8)	The metabolism of Erythromycin can be decreased when combined with Itraconazole.	#B4D1E6	2.06781458758046	1
Bisoprolol	Epinephrine	0.571	Inf	Moderate	2 (2/0)	Epinephrine may increase the atrioventricular blocking (AV block) activities of Bisoprolol.	#B32020	0.243272304421231	1
Clozapine	Fluoxetine	0.439	-12.099	Moderate	11 (1/10)	The serum concentration of Clozapine can be increased when it is combined with Fluoxetine.	#2B6BAA	1.33799767431677	0.00891247349423275
Minocycline	Cloxacillin	0.616	-1.613	Moderate	21 (9/12)	The therapeutic efficacy of Cloxacillin can be decreased when used in combination with Minocycline.	#AECDE3	2.55435919642292	1
Dihydroergotamine	Nadolol	0.5	Inf	Moderate	1 (1/0)	Dihydroergotamine may increase the atrioventricular blocking (AV block) activities of Nadolol.	#B32020	0.121636152210615	1
Dexamethasone	Acenocoumarol	0.278	-1.21	None	2 (1/1)		#B2D0E5	0.243272304421231	1
Fluconazole	Rifampicin	0.62	1.378	Major	8 (5/3)	The metabolism of Rifampicin can be decreased when combined with Fluconazole.	#F7B7B7	0.973089217684923	1
Methotrexate	Cloxacillin	0.124	1.378	Major	8 (5/3)	The serum concentration of Methotrexate can be increased when it is combined with Cloxacillin.	#F7B7B7	0.973089217684923	1
Clarithromycin	Quetiapine	0.175	1.181	Major	17 (10/7)	The serum concentration of Quetiapine can be increased when it is combined with Clarithromycin.	#F8BABA	2.06781458758046	1
Metoprolol	Salmeterol	0.2	Inf	Moderate	1 (1/0)	Metoprolol may decrease the bronchodilatory activities of Salmeterol.	#B32020	0.121636152210615	1
Labetalol	Salbutamol	0.237	Inf	Major	8 (8/0)	Labetalol may decrease the vasoconstricting activities of Salbutamol.	#B32020	0.973089217684923	1
Ethinylestradiol	Ursodeoxycholic acid	0.169	Inf	None	7 (7/0)	The therapeutic efficacy of Ursodeoxycholic acid can be decreased when used in combination with Ethinyl Estradiol.	#B32020	0.851453065474308	1
Lansoprazole	Itraconazole	0.386	1.929	Moderate	10 (7/3)	The serum concentration of Itraconazole can be decreased when it is combined with Lansoprazole.	#F4B1B1	1.21636152210615	1
Isoniazid	Acenocoumarol	0.2	Inf	None	1 (1/0)	The metabolism of Acenocoumarol can be decreased when combined with Isoniazid.	#B32020	0.121636152210615	1
Codeine	Naltrexone	0.421	-2.016	Major	8 (3/5)	The therapeutic efficacy of Codeine can be decreased when used in combination with Naltrexone.	#A8C8E1	0.973089217684923	1
Ketoconazole	Rifampicin	0.333	Inf	Major	1 (1/0)	The metabolism of Ketoconazole can be increased when combined with Rifampicin.	#B32020	0.121636152210615	1
Pantoprazole	Itraconazole	0.465	-1.059	Moderate	15 (8/7)	The serum concentration of Itraconazole can be decreased when it is combined with Pantoprazole.	#B4D1E6	1.82454228315923	1
Naratriptan	Escitalopram	0.182	Inf	Major	1 (1/0)	The risk or severity of adverse effects can be increased when Naratriptan is combined with Escitalopram.	#B32020	0.121636152210615	1
Torasemide	Indomethacin	1	Inf	Moderate	1 (1/0)	The therapeutic efficacy of Torasemide can be decreased when used in combination with Indomethacin.	#B32020	0.121636152210615	1
Paroxetine	Frovatriptan	0.1	Inf	None	3 (3/0)	The risk or severity of adverse effects can be increased when Paroxetine is combined with Frovatriptan.	#B32020	0.364908456631846	1
Trazodone	Itraconazole	0.292	4.133	Moderate	6 (5/1)	The metabolism of Trazodone can be decreased when combined with Itraconazole.	#E79494	0.729816913263693	1
Fluconazole	Tolterodine	0.123	2.48	Moderate	4 (3/1)	The metabolism of Tolterodine can be decreased when combined with Fluconazole.	#F0A9A9	0.486544608842462	1
Fluconazole	Phenytoin	0.23	1.653	Moderate	3 (2/1)	The serum concentration of Phenytoin can be increased when it is combined with Fluconazole.	#F5B4B4	0.364908456631846	1
Bisoprolol	Rifampicin	0.312	-1.21	Moderate	2 (1/1)	The metabolism of Bisoprolol can be increased when combined with Rifampicin.	#B2D0E5	0.243272304421231	1
Carbamazepine	Acenocoumarol	0.422	-2.42	None	3 (1/2)	The serum concentration of Acenocoumarol can be decreased when it is combined with Carbamazepine.	#A3C5DF	0.364908456631846	1
Tetracycline	Amoxicillin	0.611	3.719	Moderate	22 (18/4)		#E99999	2.67599534863354	1
Desogestrel	Lamotrigine	0.098	Inf	Moderate	9 (9/0)	Desogestrel may increase the excretion rate of Lamotrigine which could result in a lower serum level and potentially a reduction in efficacy.	#B32020	1.09472536989554	1
Erythromycin	Simvastatin	0.235	Inf	Major	4 (4/0)	The serum concentration of Simvastatin can be increased when it is combined with Erythromycin.	#B32020	0.486544608842462	1
Sucralfate	Ciprofloxacin	0.831	1.653	Moderate	9 (6/3)		#F5B4B4	1.09472536989554	1
Propranolol	Terbutaline	0.588	1.446	Major	11 (7/4)		#F7B7B7	1.33799767431677	1
Levofloxacin	Iron	0.498	7.852	Moderate	21 (19/2)	The serum concentration of Levofloxacin can be decreased when it is combined with Iron.	#D26565	2.55435919642292	1
Cyclosporine	Simvastatin	0.239	-3.63	Major	4 (1/3)	The serum concentration of Simvastatin can be increased when it is combined with Cyclosporine.	#94B9D8	0.486544608842462	1
Atenolol	Formoterol	0.339	-1.815	Moderate	10 (4/6)	Atenolol may decrease the bronchodilatory activities of Formoterol.	#ABCBE2	1.21636152210615	1
Atomoxetine	Fluoxetine	0.258	-4.839	Major	5 (1/4)	The serum concentration of Atomoxetine can be increased when it is combined with Fluoxetine.	#85AED1	0.608180761053077	1
Pseudoephedrine	Clomipramine	0.151	1.102	None	7 (4/3)	Clomipramine may decrease the antihypertensive activities of Pseudoephedrine.	#F9BCBC	0.851453065474308	1
Ergotamine	Almotriptan	0.461	-1.21	Major	4 (2/2)	Ergotamine may increase the vasoconstricting activities of Almotriptan.	#B2D0E5	0.486544608842462	1
Norfloxacin	Iron	0.567	Inf	None	35 (35/0)	The serum concentration of Norfloxacin can be decreased when it is combined with Iron.	#B32020	4.25726532737154	1
Losartan	Drospirenone	0.163	Inf	Moderate	3 (3/0)	Losartan may increase the hyperkalemic activities of Drospirenone.	#B32020	0.364908456631846	1
Prednisone	Ketoconazole	0.726	1.653	Moderate	9 (6/3)	The serum concentration of Prednisone can be increased when it is combined with Ketoconazole.	#F5B4B4	1.09472536989554	1
Prednisolone	Ethinylestradiol	0.305	Inf	Moderate	5 (5/0)	The serum concentration of Prednisolone can be increased when it is combined with Ethinyl Estradiol.	#B32020	0.608180761053077	1
Estradiol	Ursodeoxycholic acid	0.596	Inf	None	3 (3/0)	The therapeutic efficacy of Ursodeoxycholic acid can be decreased when used in combination with Estradiol.	#B32020	0.364908456631846	1
Citalopram	Clozapine	0.31	-2.42	Major	3 (1/2)	The serum concentration of Clozapine can be increased when it is combined with Citalopram.	#A3C5DF	0.364908456631846	1
Amitriptyline	Terbutaline	0.467	1.86	Moderate	13 (9/4)	The risk or severity of adverse effects can be increased when Amitriptyline is combined with Terbutaline.	#F5B2B2	1.581269978738	1
Methotrexate	Tetracycline	0.125	Inf	Moderate	1 (1/0)		#B32020	0.121636152210615	1
Sucralfate	Levothyroxine	0.106	Inf	Minor	4 (4/0)	The serum concentration of Levothyroxine can be decreased when it is combined with Sucralfate.	#B32020	0.486544608842462	1
Methylprednisolone	Itraconazole	0.464	1.653	Major	9 (6/3)	The serum concentration of Methylprednisolone can be increased when it is combined with Itraconazole.	#F5B4B4	1.09472536989554	1
Fludrocortisone	Acetylsalicylic acid	0.044	-1.21	Moderate	2 (1/1)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Fludrocortisone.	#B2D0E5	0.243272304421231	1
Hydrochlorothiazide	Lithium cation	0.087	-1.21	Major	2 (1/1)	Hydrochlorothiazide may decrease the excretion rate of Lithium which could result in a higher serum level.	#B2D0E5	0.243272304421231	1
Frovatriptan	Escitalopram	0.524	Inf	Major	2 (2/0)	The risk or severity of adverse effects can be increased when Frovatriptan is combined with Escitalopram.	#B32020	0.243272304421231	1
Estradiol	Phenobarbital	0.123	1.653	Moderate	3 (2/1)	The metabolism of Estradiol can be increased when combined with Phenobarbital.	#F5B4B4	0.364908456631846	1
Cyclosporine	Naproxen	0.195	4.133	Moderate	6 (5/1)	Naproxen may increase the nephrotoxic activities of Cyclosporine.	#E79494	0.729816913263693	1
Clarithromycin	Acenocoumarol	0.094	1.653	None	6 (4/2)	The metabolism of Acenocoumarol can be decreased when combined with Clarithromycin.	#F5B4B4	0.729816913263693	1
Warfarin	Itraconazole	0.25	Inf	Moderate	1 (1/0)	The serum concentration of Warfarin can be increased when it is combined with Itraconazole.	#B32020	0.121636152210615	1
Ketoconazole	Budesonide	0.418	1.653	Major	12 (8/4)	The serum concentration of Budesonide can be increased when it is combined with Ketoconazole.	#F5B4B4	1.45963382652739	1
Tacrolimus	Clarithromycin	0.633	1.929	Major	10 (7/3)	The serum concentration of Tacrolimus can be increased when it is combined with Clarithromycin.	#F4B1B1	1.21636152210615	1
Phenytoin	Sertraline	0.56	-2.42	Moderate	3 (1/2)	The serum concentration of Phenytoin can be increased when it is combined with Sertraline.	#A3C5DF	0.364908456631846	1
Ethinylestradiol	Phenobarbital	0.445	Inf	Major	4 (4/0)	The metabolism of Ethinyl Estradiol can be increased when combined with Phenobarbital.	#B32020	0.486544608842462	1
Tacrolimus	Metronidazole	0.59	1.378	Moderate	8 (5/3)		#F7B7B7	0.973089217684923	1
Atorvastatin	Josamycin	0.167	Inf	None	1 (1/0)	The risk or severity of adverse effects can be increased when Josamycin is combined with Atorvastatin.	#B32020	0.121636152210615	1
Atorvastatin	Clarithromycin	0.314	1.033	Major	9 (5/4)	The serum concentration of Atorvastatin can be increased when it is combined with Clarithromycin.	#F9BCBC	1.09472536989554	1
Tizanidine	Lisinopril	0.111	Inf	Major	1 (1/0)	Tizanidine may increase the hypotensive activities of Lisinopril.	#B32020	0.121636152210615	1
Theophylline	Propranolol	0.167	Inf	Major	1 (1/0)	The metabolism of Propranolol can be decreased when combined with Theophylline.	#B32020	0.121636152210615	1
Digoxin	Diazepam	0.264	-2.42	Moderate	6 (2/4)		#A3C5DF	0.729816913263693	1
Azithromycin	Lovastatin	0.142	Inf	Moderate	2 (2/0)	The serum concentration of Lovastatin can be increased when it is combined with Azithromycin.	#B32020	0.243272304421231	1
Hydrocortisone	Phenobarbital	0.342	-2.42	Moderate	3 (1/2)	The serum concentration of Hydrocortisone can be decreased when it is combined with Phenobarbital.	#A3C5DF	0.364908456631846	1
Celecoxib	Rifampicin	0.333	Inf	Moderate	1 (1/0)	The metabolism of Celecoxib can be increased when combined with Rifampicin.	#B32020	0.121636152210615	1
Diclofenac	Rifampicin	0.366	-2.074	Moderate	19 (7/12)	The serum concentration of Diclofenac can be decreased when it is combined with Rifampicin.	#A8C8E1	2.31108689200169	1
Paroxetine	Pimozide	0.154	Inf	Major	1 (1/0)	The serum concentration of Pimozide can be increased when it is combined with Paroxetine.	#B32020	0.121636152210615	1
Erythromycin	Methylergometrine	0.833	Inf	None	3 (3/0)	The risk or severity of adverse effects can be increased when Methylergometrine is combined with Erythromycin.	#B32020	0.364908456631846	1
Terbutaline	Clomipramine	0.157	1.24	Moderate	5 (3/2)	The risk or severity of adverse effects can be increased when Clomipramine is combined with Terbutaline.	#F8BABA	0.608180761053077	1
Tetracycline	Iron	0.767	Inf	Moderate	5 (5/0)		#B32020	0.608180761053077	1
Propranolol	Phenobarbital	0.318	-3.63	Moderate	4 (1/3)	The metabolism of Propranolol can be increased when combined with Phenobarbital.	#94B9D8	0.486544608842462	1
Rifampicin	Etoricoxib	0.1	Inf	None	1 (1/0)	The metabolism of Etoricoxib can be increased when combined with Rifampicin.	#B32020	0.121636152210615	1
Paroxetine	Naratriptan	0.429	Inf	Major	1 (1/0)	The risk or severity of adverse effects can be increased when Paroxetine is combined with Naratriptan.	#B32020	0.121636152210615	1
Salbutamol	Nadolol	0.289	4.133	Major	6 (5/1)		#E79494	0.729816913263693	1
Norfloxacin	Acenocoumarol	0.111	Inf	None	4 (4/0)	Norfloxacin may increase the anticoagulant activities of Acenocoumarol.	#B32020	0.486544608842462	1
Fluoxetine	Warfarin	0.273	Inf	Moderate	1 (1/0)	The metabolism of Warfarin can be decreased when combined with Fluoxetine.	#B32020	0.121636152210615	1
Atomoxetine	Paroxetine	0.218	-7.259	Major	7 (1/6)	The serum concentration of Atomoxetine can be increased when it is combined with Paroxetine.	#6898C5	0.851453065474308	1
Metoprolol	Escitalopram	0.143	Inf	Minor	1 (1/0)	The serum concentration of Metoprolol can be increased when it is combined with Escitalopram.	#B32020	0.121636152210615	1
Griseofulvin	Estradiol	0.273	Inf	Moderate	1 (1/0)	The metabolism of Estradiol can be increased when combined with Griseofulvin.	#B32020	0.121636152210615	1
Phenytoin	Itraconazole	0.042	Inf	Moderate	1 (1/0)	The serum concentration of Itraconazole can be decreased when it is combined with Phenytoin.	#B32020	0.121636152210615	1
Metoprolol	Salbutamol	0.5	Inf	Moderate	2 (2/0)	Metoprolol may decrease the bronchodilatory activities of Salbutamol.	#B32020	0.243272304421231	1
Diazepam	Rifampicin	0.328	-1.613	Minor	14 (6/8)	The metabolism of Diazepam can be increased when combined with Rifampicin.	#AECDE3	1.70290613094862	1
Fluvoxamine	Almotriptan	0.214	Inf	Major	1 (1/0)	The metabolism of Almotriptan can be decreased when combined with Fluvoxamine.	#B32020	0.121636152210615	1
Fluoxetine	Josamycin	0.134	-1.21	None	6 (3/3)		#B2D0E5	0.729816913263693	1
Ethinylestradiol	Acenocoumarol	0.207	Inf	None	6 (6/0)	Ethinyl Estradiol may decrease the anticoagulant activities of Acenocoumarol.	#B32020	0.729816913263693	1
Erythromycin	Bromocriptine	0.278	Inf	Moderate	2 (2/0)	The risk or severity of adverse effects can be increased when Bromocriptine is combined with Erythromycin.	#B32020	0.243272304421231	1
Lorazepam	Clozapine	0.306	-9.679	Major	9 (1/8)	The risk or severity of adverse effects can be increased when Lorazepam is combined with Clozapine.	#4A82B8	1.09472536989554	1
Estradiol	Prednisolone	0.269	Inf	Moderate	2 (2/0)	The serum concentration of Prednisolone can be increased when it is combined with Estradiol.	#B32020	0.243272304421231	1
Fluconazole	Halazepam	0.75	Inf	None	2 (2/0)		#B32020	0.243272304421231	1
Indomethacin	Acenocoumarol	1	Inf	None	1 (1/0)	Indomethacin may increase the anticoagulant activities of Acenocoumarol.	#B32020	0.121636152210615	1
Clarithromycin	Solifenacin	0.402	2.48	Major	4 (3/1)	The metabolism of Solifenacin can be decreased when combined with Clarithromycin.	#F0A9A9	0.486544608842462	1
Enalapril	Lithium cation	0.196	-6.049	Moderate	6 (1/5)	The serum concentration of Lithium can be increased when it is combined with Enalapril.	#76A3CB	0.729816913263693	1
Amitriptyline	Pseudoephedrine	0.297	3.306	None	10 (8/2)	Amitriptyline may decrease the antihypertensive activities of Pseudoephedrine.	#EC9F9F	1.21636152210615	1
Enalapril	Rifampicin	0.267	-3.63	None	4 (1/3)	The metabolism of Enalapril can be increased when combined with Rifampicin.	#94B9D8	0.486544608842462	1
Epinephrine	Nadolol	0.143	Inf	Major	1 (1/0)	Epinephrine may increase the atrioventricular blocking (AV block) activities of Nadolol.	#B32020	0.121636152210615	1
Doxycycline	Acenocoumarol	0.211	-3.63	None	8 (2/6)	The metabolism of Acenocoumarol can be decreased when combined with Doxycycline.	#94B9D8	0.973089217684923	1
Erythromycin	Cabergoline	0.717	Inf	Major	5 (5/0)	The risk or severity of adverse effects can be increased when Cabergoline is combined with Erythromycin.	#B32020	0.608180761053077	1
Repaglinide	Clarithromycin	0.2	Inf	Moderate	1 (1/0)	The serum concentration of Repaglinide can be increased when it is combined with Clarithromycin.	#B32020	0.121636152210615	1
Fluconazole	Midazolam	0.625	Inf	Major	2 (2/0)	The metabolism of Midazolam can be decreased when combined with Fluconazole.	#B32020	0.243272304421231	1
Ergotamine	Clarithromycin	0.7	Inf	Major	5 (5/0)	The serum concentration of Ergotamine can be increased when it is combined with Clarithromycin.	#B32020	0.608180761053077	1
Pimozide	Clarithromycin	0.031	-1.21	Major	2 (1/1)	The risk or severity of ventricular arrhythmias can be increased when Clarithromycin is combined with Pimozide.	#B2D0E5	0.243272304421231	1
Trospium	Loratadine	0.25	Inf	None	1 (1/0)		#B32020	0.121636152210615	1
Theophylline	Ethinylestradiol	0.079	Inf	None	3 (3/0)	The serum concentration of Theophylline can be increased when it is combined with Ethinyl Estradiol.	#B32020	0.364908456631846	1
Prednisolone	Acetylsalicylic acid	1	Inf	Moderate	1 (1/0)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Prednisolone.	#B32020	0.121636152210615	1
Enalapril	Tizanidine	0.233	-3.025	Major	7 (2/5)	The risk or severity of hypotension can be increased when Tizanidine is combined with Enalapril.	#9CBFDB	0.851453065474308	1
Ergotamine	Itraconazole	0.667	Inf	Major	3 (3/0)	The serum concentration of Ergotamine can be increased when it is combined with Itraconazole.	#B32020	0.364908456631846	1
Eletriptan	Clarithromycin	0.073	2.48	Major	4 (3/1)	The serum concentration of Eletriptan can be increased when it is combined with Clarithromycin.	#F0A9A9	0.486544608842462	1
Alprazolam	Telithromycin	0.067	Inf	Moderate	1 (1/0)	The serum concentration of Alprazolam can be increased when it is combined with Telithromycin.	#B32020	0.121636152210615	1
Sotalol	Ibuprofen	0.181	-2.42	Moderate	6 (2/4)	Ibuprofen may decrease the antihypertensive activities of Sotalol.	#A3C5DF	0.729816913263693	1
Prednisone	Phenobarbital	0.141	-4.839	Moderate	10 (2/8)	The serum concentration of Prednisone can be decreased when it is combined with Phenobarbital.	#85AED1	1.21636152210615	1
Hydrocortisone	Cholestyramine	0.167	Inf	Moderate	1 (1/0)	Cholestyramine can cause a decrease in the absorption of Hydrocortisone resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B32020	0.121636152210615	1
Fluconazole	Lovastatin	0.25	Inf	Major	1 (1/0)	The serum concentration of Lovastatin can be increased when it is combined with Fluconazole.	#B32020	0.121636152210615	1
Indomethacin	Furosemide	1	Inf	Moderate	1 (1/0)	The therapeutic efficacy of Furosemide can be decreased when used in combination with Indomethacin.	#B32020	0.121636152210615	1
Warfarin	Ranitidine	0.103	-1.21	Moderate	2 (1/1)	The serum concentration of Warfarin can be increased when it is combined with Ranitidine.	#B2D0E5	0.243272304421231	1
Rifampicin	Clarithromycin	0.54	-2.823	Moderate	10 (3/7)	The serum concentration of the active metabolites of Clarithromycin can be increased when Clarithromycin is used in combination with Rifampicin.	#9FC1DD	1.21636152210615	1
Trazodone	Ketoconazole	0.333	Inf	Moderate	1 (1/0)	The metabolism of Trazodone can be decreased when combined with Ketoconazole.	#B32020	0.121636152210615	1
Ethinylestradiol	Ketoconazole	0.144	Inf	Moderate	6 (6/0)	The metabolism of Ethinyl Estradiol can be decreased when combined with Ketoconazole.	#B32020	0.729816913263693	1
Dihydroergotamine	Nitroglycerin	1	Inf	Moderate	1 (1/0)	The bioavailability of Dihydroergotamine can be increased when combined with Nitroglycerin.	#B32020	0.121636152210615	1
Omeprazole	Cilostazol	0.094	-1.21	Major	2 (1/1)	The serum concentration of Cilostazol can be increased when it is combined with Omeprazole.	#B2D0E5	0.243272304421231	1
Triamcinolone	Acetylsalicylic acid	0.621	-1.21	Moderate	6 (3/3)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Triamcinolone.	#B2D0E5	0.729816913263693	1
Clozapine	Alprazolam	0.318	-8.469	Major	8 (1/7)	The risk or severity of adverse effects can be increased when Alprazolam is combined with Clozapine.	#598DBE	0.973089217684923	1
Bisoprolol	Terbutaline	0.241	-3.025	Moderate	7 (2/5)	Bisoprolol may decrease the bronchodilatory activities of Terbutaline.	#9CBFDB	0.851453065474308	1
Oxycodone	Paroxetine	0.458	-2.42	Moderate	3 (1/2)	The metabolism of Oxycodone can be decreased when combined with Paroxetine.	#A3C5DF	0.364908456631846	1
Labetalol	Epinephrine	0.5	Inf	Major	1 (1/0)	Epinephrine may increase the atrioventricular blocking (AV block) activities of Labetalol.	#B32020	0.121636152210615	1
Formoterol	Carvedilol	0.542	-1.21	Major	2 (1/1)	Carvedilol may decrease the vasoconstricting activities of Formoterol.	#B2D0E5	0.243272304421231	1
Fluvoxamine	Tramadol	0.078	-1.21	Major	4 (2/2)	Fluvoxamine may increase the neuroexcitatory activities of Tramadol.	#B2D0E5	0.486544608842462	1
Fluconazole	Celecoxib	0.356	1.653	Moderate	6 (4/2)	The metabolism of Celecoxib can be decreased when combined with Fluconazole.	#F5B4B4	0.729816913263693	1
Ibandronate	Iron	0.111	Inf	Moderate	1 (1/0)		#B32020	0.121636152210615	1
Fluconazole	Ergotamine	0.675	Inf	Moderate	4 (4/0)	The metabolism of Ergotamine can be decreased when combined with Fluconazole.	#B32020	0.486544608842462	1
Fluconazole	Dihydroergotamine	0.353	1.24	Moderate	5 (3/2)	The metabolism of Dihydroergotamine can be decreased when combined with Fluconazole.	#F8BABA	0.608180761053077	1
Fluvoxamine	Sumatriptan	0.232	-1.21	Major	2 (1/1)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Sumatriptan.	#B2D0E5	0.243272304421231	1
Indomethacin	Bisoprolol	0.167	Inf	Moderate	1 (1/0)	Indomethacin may decrease the antihypertensive activities of Bisoprolol.	#B32020	0.121636152210615	1
Fentanyl	Itraconazole	0.5	Inf	Major	1 (1/0)	The serum concentration of Fentanyl can be increased when it is combined with Itraconazole.	#B32020	0.121636152210615	1
Moxifloxacin	Acenocoumarol	0.276	-1.21	None	2 (1/1)		#B2D0E5	0.243272304421231	1
Amitriptyline	Ketoconazole	0.267	Inf	Moderate	2 (2/0)	The metabolism of Amitriptyline can be decreased when combined with Ketoconazole.	#B32020	0.243272304421231	1
Bisoprolol	Insulin aspart	0.215	-7.259	Moderate	7 (1/6)		#6898C5	0.851453065474308	1
Bumetanide	Ibuprofen	0.167	Inf	Moderate	1 (1/0)	The therapeutic efficacy of Bumetanide can be decreased when used in combination with Ibuprofen.	#B32020	0.121636152210615	1
Cyclosporine	Norfloxacin	0.076	Inf	Moderate	2 (2/0)	The metabolism of Cyclosporine can be decreased when combined with Norfloxacin.	#B32020	0.243272304421231	1
Sumatriptan	Lithium cation	0.182	-6.049	None	6 (1/5)	The risk or severity of adverse effects can be increased when Sumatriptan is combined with Lithium.	#76A3CB	0.729816913263693	1
Diclofenac	Alendronic acid	0.641	-2.016	Moderate	8 (3/5)	The risk or severity of adverse effects can be increased when Diclofenac is combined with Alendronic acid.	#A8C8E1	0.973089217684923	1
Diazepam	Ketoconazole	0.412	-1.21	Moderate	10 (5/5)	The metabolism of Diazepam can be decreased when combined with Ketoconazole.	#B2D0E5	1.21636152210615	1
Esomeprazole	Ketoconazole	0.333	Inf	Moderate	1 (1/0)	The serum concentration of Ketoconazole can be decreased when it is combined with Esomeprazole.	#B32020	0.121636152210615	1
Sucralfate	Norfloxacin	0.75	Inf	Moderate	3 (3/0)	The serum concentration of Norfloxacin can be decreased when it is combined with Sucralfate.	#B32020	0.364908456631846	1
Cyclosporine	Diclofenac	0.202	-2.016	Moderate	8 (3/5)	Diclofenac may increase the nephrotoxic activities of Cyclosporine.	#A8C8E1	0.973089217684923	1
Ranitidine	Acenocoumarol	0.328	-4.839	None	10 (2/8)		#85AED1	1.21636152210615	1
Thiethylperazine	Bromocriptine	1	Inf	Moderate	1 (1/0)		#B32020	0.121636152210615	1
Frovatriptan	Sertraline	0.143	Inf	Major	1 (1/0)	The risk or severity of adverse effects can be increased when Frovatriptan is combined with Sertraline.	#B32020	0.121636152210615	1
Haloperidol	Itraconazole	1	Inf	Moderate	1 (1/0)	The metabolism of Haloperidol can be decreased when combined with Itraconazole.	#B32020	0.121636152210615	1
Itraconazole	Aripiprazole	0.094	-1.21	Moderate	4 (2/2)	The serum concentration of Aripiprazole can be increased when it is combined with Itraconazole.	#B2D0E5	0.486544608842462	1
Cyclosporine	Itraconazole	0.085	-1.21	Major	2 (1/1)	The metabolism of Cyclosporine can be decreased when combined with Itraconazole.	#B2D0E5	0.243272304421231	1
Hydrocortisone	Rifampicin	0.146	-1.21	Moderate	2 (1/1)	The serum concentration of Hydrocortisone can be decreased when it is combined with Rifampicin.	#B2D0E5	0.243272304421231	1
Phenytoin	Clarithromycin	0.124	-1.21	Moderate	2 (1/1)	The serum concentration of the active metabolites of Clarithromycin can be increased when Clarithromycin is used in combination with Phenytoin.	#B2D0E5	0.243272304421231	1
Labetalol	Formoterol	0.35	Inf	Major	2 (2/0)	Labetalol may decrease the vasoconstricting activities of Formoterol.	#B32020	0.243272304421231	1
Phenoxymethylpenicillin	Minocycline	0.833	Inf	Moderate	3 (3/0)	The therapeutic efficacy of Phenoxymethylpenicillin can be decreased when used in combination with Minocycline.	#B32020	0.364908456631846	1
Tizanidine	Norethisterone	0.5	Inf	Major	1 (1/0)		#B32020	0.121636152210615	1
Ciprofloxacin	Warfarin	0.317	-4.839	Major	5 (1/4)		#85AED1	0.608180761053077	1
Minocycline	Iron	0.461	Inf	Moderate	6 (6/0)	Minocycline can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B32020	0.729816913263693	1
Moxifloxacin	Iron	0.51	4.959	Moderate	7 (6/1)		#E28989	0.851453065474308	1
Conjugated estrogens	Prednisone	0.241	Inf	Moderate	1 (1/0)	The serum concentration of Prednisone can be increased when it is combined with Conjugated estrogens.	#B32020	0.121636152210615	1
Methylprednisolone	Ketoconazole	1	Inf	Major	1 (1/0)	The serum concentration of Methylprednisolone can be increased when it is combined with Ketoconazole.	#B32020	0.121636152210615	1
Fluconazole	Flurazepam	0.111	Inf	None	1 (1/0)	The metabolism of Flurazepam can be decreased when combined with Fluconazole.	#B32020	0.121636152210615	1
Doxycycline	Insulin detemir	0.025	-1.21	Moderate	2 (1/1)		#B2D0E5	0.243272304421231	1
Fluconazole	Imipramine	0.2	Inf	Moderate	1 (1/0)	The metabolism of Imipramine can be decreased when combined with Fluconazole.	#B32020	0.121636152210615	1
Olmesartan	Drospirenone	0.227	Inf	Moderate	1 (1/0)	Olmesartan may increase the hyperkalemic activities of Drospirenone.	#B32020	0.121636152210615	1
Dextromethorphan	Terbinafine	0.37	-1.21	Major	8 (4/4)	The metabolism of Dextromethorphan can be decreased when combined with Terbinafine.	#B2D0E5	0.973089217684923	1
Diazepam	Josamycin	0.248	3.306	None	5 (4/1)		#EC9F9F	0.608180761053077	1
Phenytoin	Ciprofloxacin	0.201	-8.469	Moderate	8 (1/7)	The therapeutic efficacy of Phenytoin can be decreased when used in combination with Ciprofloxacin.	#598DBE	0.973089217684923	1
Methylergometrine	Epinephrine	0.333	Inf	Major	1 (1/0)	The risk or severity of adverse effects can be increased when Methylergometrine is combined with Epinephrine.	#B32020	0.121636152210615	1
Fluoxetine	Frovatriptan	0.071	Inf	Major	1 (1/0)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Frovatriptan.	#B32020	0.121636152210615	1
Doxycycline	Ampicillin	1	-1.21	Moderate	2 (1/1)	The therapeutic efficacy of Ampicillin can be decreased when used in combination with Doxycycline.	#B2D0E5	0.243272304421231	1
Erythromycin	Dihydroergotamine	0.062	Inf	Major	1 (1/0)	The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Erythromycin.	#B32020	0.121636152210615	1
Ketoconazole	Clonazepam	0.5	Inf	None	1 (1/0)	The metabolism of Clonazepam can be decreased when combined with Ketoconazole.	#B32020	0.121636152210615	1
Medroxyprogesterone acetate	Acenocoumarol	0.111	Inf	None	1 (1/0)	Medroxyprogesterone acetate may decrease the anticoagulant activities of Acenocoumarol.	#B32020	0.121636152210615	1
Itraconazole	Solifenacin	0.306	-1.21	Major	2 (1/1)	The metabolism of Solifenacin can be decreased when combined with Itraconazole.	#B2D0E5	0.243272304421231	1
Disulfiram	Metronidazole	0.263	-7.259	Major	7 (1/6)	The risk or severity of adverse effects can be increased when Disulfiram is combined with Metronidazole.	#6898C5	0.851453065474308	1
Erythromycin	Atorvastatin	1	Inf	Major	1 (1/0)	The serum concentration of Atorvastatin can be increased when it is combined with Erythromycin.	#B32020	0.121636152210615	1
Levofloxacin	Acenocoumarol	0.127	-6.049	None	6 (1/5)	Levofloxacin may increase the anticoagulant activities of Acenocoumarol.	#76A3CB	0.729816913263693	1
Ramipril	Drospirenone	0.16	Inf	Moderate	1 (1/0)	Ramipril may increase the hyperkalemic activities of Drospirenone.	#B32020	0.121636152210615	1
Fluvoxamine	Amitriptyline	0.298	-2.42	Major	3 (1/2)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Amitriptyline.	#A3C5DF	0.364908456631846	1
Azithromycin	Warfarin	0.065	-2.42	Moderate	3 (1/2)	The metabolism of Warfarin can be decreased when combined with Azithromycin.	#A3C5DF	0.364908456631846	1
Erythromycin	Carbamazepine	0.046	-1.21	Major	2 (1/1)	The metabolism of Carbamazepine can be decreased when combined with Erythromycin.	#B2D0E5	0.243272304421231	1
Itraconazole	Acenocoumarol	0.091	Inf	None	1 (1/0)	The serum concentration of Acenocoumarol can be increased when it is combined with Itraconazole.	#B32020	0.121636152210615	1
Lisinopril	Drospirenone	0.8	Inf	Moderate	1 (1/0)	Lisinopril may increase the hyperkalemic activities of Drospirenone.	#B32020	0.121636152210615	1
Esomeprazole	Itraconazole	0.447	-1.21	Moderate	4 (2/2)	The serum concentration of Itraconazole can be decreased when it is combined with Esomeprazole.	#B2D0E5	0.486544608842462	1
Rifampicin	Itraconazole	0.75	-1.21	Major	2 (1/1)	The serum concentration of Itraconazole can be decreased when it is combined with Rifampicin.	#B2D0E5	0.243272304421231	1
Midazolam	Clarithromycin	0.244	-3.63	Moderate	4 (1/3)	The serum concentration of Midazolam can be increased when it is combined with Clarithromycin.	#94B9D8	0.486544608842462	1
Theophylline	Ciprofloxacin	0.567	-2.42	Major	3 (1/2)		#A3C5DF	0.364908456631846	1
Imipramine	Salbutamol	0.034	Inf	Moderate	1 (1/0)	The risk or severity of adverse effects can be increased when Imipramine is combined with Salbutamol.	#B32020	0.121636152210615	1
Atenolol	Terbutaline	0.486	-2.42	Moderate	3 (1/2)	Atenolol may decrease the bronchodilatory activities of Terbutaline.	#A3C5DF	0.364908456631846	1
Fluconazole	Haloperidol	0.478	-2.42	Major	3 (1/2)	The metabolism of Haloperidol can be decreased when combined with Fluconazole.	#A3C5DF	0.364908456631846	1
Labetalol	Terbutaline	1	Inf	Major	1 (1/0)	The risk or severity of adverse effects can be increased when Labetalol is combined with Terbutaline.	#B32020	0.121636152210615	1
Warfarin	Naproxen	0.167	Inf	Major	1 (1/0)	Naproxen may increase the anticoagulant activities of Warfarin.	#B32020	0.121636152210615	1
Cyclosporine	Clarithromycin	0.05	-1.21	Major	2 (1/1)	The metabolism of Cyclosporine can be decreased when combined with Clarithromycin.	#B2D0E5	0.243272304421231	1
Ampicillin	Ethinylestradiol	0.778	Inf	Moderate	2 (2/0)		#B32020	0.243272304421231	1
Sucralfate	Itraconazole	0.35	-1.21	None	2 (1/1)	Sucralfate can cause a decrease in the absorption of Itraconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B2D0E5	0.243272304421231	1
Metronidazole	Lithium cation	0.04	-2.42	Moderate	3 (1/2)		#A3C5DF	0.364908456631846	1
Dihydroergotamine	Itraconazole	0.264	-2.42	Major	3 (1/2)	The serum concentration of Dihydroergotamine can be increased when it is combined with Itraconazole.	#A3C5DF	0.364908456631846	1
Doxycycline	Phenoxymethylpenicillin	0.643	-1.613	Moderate	7 (3/4)	The therapeutic efficacy of Phenoxymethylpenicillin can be decreased when used in combination with Doxycycline.	#AECDE3	0.851453065474308	1
Itraconazole	Josamycin	0.75	-1.21	None	2 (1/1)		#B2D0E5	0.243272304421231	1
Phenoxymethylpenicillin	Methotrexate	0.031	Inf	Major	1 (1/0)	The serum concentration of Methotrexate can be increased when it is combined with Phenoxymethylpenicillin.	#B32020	0.121636152210615	1
Propranolol	Epinephrine	0.238	-1.21	Major	2 (1/1)	Epinephrine may increase the atrioventricular blocking (AV block) activities of Propranolol.	#B2D0E5	0.243272304421231	1
Erythromycin	Quetiapine	0.208	-1.21	Major	2 (1/1)	The metabolism of Quetiapine can be decreased when combined with Erythromycin.	#B2D0E5	0.243272304421231	1
Ranitidine	Ketoconazole	0.417	-1.21	Moderate	2 (1/1)	The serum concentration of Ketoconazole can be decreased when it is combined with Ranitidine.	#B2D0E5	0.243272304421231	1
Thiethylperazine	Levofloxacin	1	Inf	None	1 (1/0)		#B32020	0.121636152210615	1
Spironolactone	Mitotane	0.6	-Inf	Major	1 (0/1)	The therapeutic efficacy of Mitotane can be decreased when used in combination with Spironolactone.	#1E61A5	0.121636152210615	0.385941780072076
Spironolactone	Benazepril	0.571	-Inf	Major	1 (0/1)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Benazepril.	#1E61A5	0.121636152210615	1
Colestipol	Warfarin	0.5	-Inf	Minor	1 (0/1)	Colestipol can cause a decrease in the absorption of Warfarin resulting in a reduced serum concentration and potentially a decrease in efficacy.	#1E61A5	0.121636152210615	1
Clonidine	Doxepin	0.103	-Inf	Major	1 (0/1)	Doxepin may decrease the antihypertensive activities of Clonidine.	#1E61A5	0.121636152210615	1
Clozapine	Haloperidol	0.161	-Inf	Major	9 (0/9)	Clozapine may increase the QTc-prolonging activities of Haloperidol.	#1E61A5	1.09472536989554	2.08625395426944e-11
Dextropropoxyphene	Naltrexone	0.325	-Inf	None	4 (0/4)	The therapeutic efficacy of Dextropropoxyphene can be decreased when used in combination with Naltrexone.	#1E61A5	0.486544608842462	2.18183755331764e-05
Spironolactone	Eplerenone	0.186	-Inf	Major	2 (0/2)	Eplerenone may increase the hyperkalemic activities of Spironolactone.	#1E61A5	0.243272304421231	0.132392353217044
Verapamil	Lithium cation	0.377	-Inf	Moderate	7 (0/7)	Verapamil may increase the neurotoxic activities of Lithium.	#1E61A5	0.851453065474308	7.66705035674862e-06
Spironolactone	Telmisartan	0.385	-Inf	Major	3 (0/3)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Telmisartan.	#1E61A5	0.364908456631846	0.0227596558478151
Clozapine	Lamotrigine	0.303	-Inf	Moderate	7 (0/7)	The risk or severity of adverse effects can be increased when Clozapine is combined with Lamotrigine.	#1E61A5	0.851453065474308	3.81516282810261e-05
Theophylline	Cimetidine	1	-Inf	Moderate	1 (0/1)	The metabolism of Theophylline can be decreased when combined with Cimetidine.	#1E61A5	0.121636152210615	1
Donepezil	Clomipramine	0.308	-Inf	Moderate	1 (0/1)	The metabolism of Donepezil can be decreased when combined with Clomipramine.	#1E61A5	0.121636152210615	1
Chlorthalidone	Digoxin	0.174	-Inf	Moderate	1 (0/1)	The risk or severity of adverse effects can be increased when Chlorthalidone is combined with Digoxin.	#1E61A5	0.121636152210615	1
Propafenone	Acenocoumarol	0.667	-Inf	None	2 (0/2)	The serum concentration of Acenocoumarol can be increased when it is combined with Propafenone.	#1E61A5	0.243272304421231	0.506641221811033
Disopyramide	Propranolol	0.133	-Inf	Major	1 (0/1)	Disopyramide may increase the bradycardic activities of Propranolol.	#1E61A5	0.121636152210615	1
Clozapine	Flunitrazepam	0.7	-Inf	None	2 (0/2)	The risk or severity of adverse effects can be increased when Flunitrazepam is combined with Clozapine.	#1E61A5	0.243272304421231	0.119817248446201
Diltiazem	Atorvastatin	0.653	-Inf	Moderate	4 (0/4)	The serum concentration of Diltiazem can be increased when it is combined with Atorvastatin.	#1E61A5	0.486544608842462	0.12354811807267
Fluvoxamine	Clozapine	0.406	-Inf	Moderate	4 (0/4)	The serum concentration of Clozapine can be increased when it is combined with Fluvoxamine.	#1E61A5	0.486544608842462	0.0218714092881502
Colestipol	Acenocoumarol	0.5	-Inf	None	1 (0/1)	Colestipol can cause a decrease in the absorption of Acenocoumarol resulting in a reduced serum concentration and potentially a decrease in efficacy.	#1E61A5	0.121636152210615	1
Phenytoin	Levodopa	0.735	-Inf	Moderate	1 (0/1)	The therapeutic efficacy of Levodopa can be decreased when used in combination with Phenytoin.	#1E61A5	0.121636152210615	1
Amitriptyline	Donepezil	0.577	-Inf	Moderate	1 (0/1)		#1E61A5	0.121636152210615	1
Cyclophosphamide	Acenocoumarol	0.75	-Inf	None	1 (0/1)		#1E61A5	0.121636152210615	1
Amiodarone	Flecainide	0.5	-Inf	Major	1 (0/1)	The serum concentration of Flecainide can be increased when it is combined with Amiodarone.	#1E61A5	0.121636152210615	1
Glimepiride	Gemfibrozil	0.305	-Inf	Moderate	2 (0/2)	The metabolism of Glimepiride can be decreased when combined with Gemfibrozil.	#1E61A5	0.243272304421231	1
Digoxin	Telmisartan	0.273	-Inf	Moderate	1 (0/1)	The serum concentration of Digoxin can be increased when it is combined with Telmisartan.	#1E61A5	0.121636152210615	1
Propranolol	Primidone	0.225	-Inf	Moderate	2 (0/2)	The metabolism of Propranolol can be increased when combined with Primidone.	#1E61A5	0.243272304421231	1
Ezetimibe	Cholestyramine	0.583	-Inf	Moderate	2 (0/2)	Cholestyramine can cause a decrease in the absorption of Ezetimibe resulting in a reduced serum concentration and potentially a decrease in efficacy.	#1E61A5	0.243272304421231	1
Metoprolol	Ergotamine	1	-Inf	Moderate	1 (0/1)	Ergotamine may increase the atrioventricular blocking (AV block) activities of Metoprolol.	#1E61A5	0.121636152210615	1
Methotrexate	Phenylbutazone	0.111	-Inf	Major	1 (0/1)	The serum concentration of Methotrexate can be increased when it is combined with Phenylbutazone.	#1E61A5	0.121636152210615	1
Methotrexate	Flurbiprofen	0.267	-Inf	Major	1 (0/1)	The serum concentration of Methotrexate can be increased when it is combined with Flurbiprofen.	#1E61A5	0.121636152210615	1
Dihydroergotamine	Frovatriptan	1	-Inf	Major	1 (0/1)	Dihydroergotamine may increase the vasoconstricting activities of Frovatriptan.	#1E61A5	0.121636152210615	1
Phenytoin	Methotrexate	0.089	-Inf	Moderate	3 (0/3)	The serum concentration of Phenytoin can be decreased when it is combined with Methotrexate.	#1E61A5	0.364908456631846	1
Fenofibrate	Fluvastatin	0.583	-Inf	Major	2 (0/2)	The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibrate is combined with Fluvastatin.	#1E61A5	0.243272304421231	1
Fluvoxamine	Imipramine	0.226	-Inf	Major	2 (0/2)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Imipramine.	#1E61A5	0.243272304421231	1
Furosemide	Gentamicin	0.5	-Inf	Major	1 (0/1)	The serum concentration of Gentamicin can be increased when it is combined with Furosemide.	#1E61A5	0.121636152210615	1
Warfarin	Azathioprine	0.583	-Inf	Moderate	2 (0/2)	Azathioprine may decrease the anticoagulant activities of Warfarin.	#1E61A5	0.243272304421231	1
Digoxin	Methimazole	0.115	-Inf	Moderate	1 (0/1)	The serum concentration of Digoxin can be increased when it is combined with Methimazole.	#1E61A5	0.121636152210615	1
Cyclosporine	Sevelamer	0.022	-Inf	Moderate	1 (0/1)	The serum concentration of Cyclosporine can be decreased when it is combined with Sevelamer.	#1E61A5	0.121636152210615	1
Cyclosporine	Lovastatin	0.25	-Inf	Major	1 (0/1)	The serum concentration of Lovastatin can be increased when it is combined with Cyclosporine.	#1E61A5	0.121636152210615	1
Glyburide	Carvedilol	0.043	-Inf	Moderate	1 (0/1)	Carvedilol may increase the hypoglycemic activities of Glyburide.	#1E61A5	0.121636152210615	1
Clozapine	Halazepam	0.875	-Inf	Major	1 (0/1)	The risk or severity of adverse effects can be increased when Clozapine is combined with Halazepam.	#1E61A5	0.121636152210615	1
Cimetidine	Carbamazepine	0.023	-Inf	Moderate	1 (0/1)	The serum concentration of Carbamazepine can be increased when it is combined with Cimetidine.	#1E61A5	0.121636152210615	1
Metformin	Cimetidine	1	-Inf	Moderate	1 (0/1)	The serum concentration of Metformin can be increased when it is combined with Cimetidine.	#1E61A5	0.121636152210615	1
Cyclosporine	Allopurinol	0.289	-Inf	Moderate	3 (0/3)		#1E61A5	0.364908456631846	1
Colestipol	Levothyroxine	0.273	-Inf	Moderate	1 (0/1)	The serum concentration of Levothyroxine can be decreased when it is combined with Colestipol.	#1E61A5	0.121636152210615	1
Atenolol	Gliclazide	0.667	-Inf	None	2 (0/2)	Atenolol may increase the hypoglycemic activities of Gliclazide.	#1E61A5	0.243272304421231	1
Diltiazem	Propranolol	0.063	-Inf	Major	2 (0/2)	The metabolism of Propranolol can be decreased when combined with Diltiazem.	#1E61A5	0.243272304421231	1
Trimipramine	Pseudoephedrine	0.2	-Inf	None	1 (0/1)	Trimipramine may decrease the antihypertensive activities of Pseudoephedrine.	#1E61A5	0.121636152210615	1
Naltrexone	Buprenorphine	1	-Inf	Major	1 (0/1)	The therapeutic efficacy of Buprenorphine can be decreased when used in combination with Naltrexone.	#1E61A5	0.121636152210615	1
Methimazole	Acenocoumarol	0.287	-Inf	None	2 (0/2)	Methimazole may decrease the anticoagulant activities of Acenocoumarol.	#1E61A5	0.243272304421231	1
Colestipol	Hydrocortisone	0.75	-Inf	Moderate	1 (0/1)	Colestipol can cause a decrease in the absorption of Hydrocortisone resulting in a reduced serum concentration and potentially a decrease in efficacy.	#1E61A5	0.121636152210615	1
Clonidine	Bisoprolol	0.286	-Inf	Major	1 (0/1)	Clonidine may increase the atrioventricular blocking (AV block) activities of Bisoprolol.	#1E61A5	0.121636152210615	1
Clozapine	Midazolam	0.111	-Inf	Major	1 (0/1)	The risk or severity of adverse effects can be increased when Midazolam is combined with Clozapine.	#1E61A5	0.121636152210615	1
Trospium	Olanzapine	0.75	-Inf	Moderate	1 (0/1)		#1E61A5	0.121636152210615	1
Propranolol	Propafenone	0.032	-Inf	Moderate	1 (0/1)	The serum concentration of Propranolol can be increased when it is combined with Propafenone.	#1E61A5	0.121636152210615	1
Testosterone	Acenocoumarol	0.203	-Inf	None	3 (0/3)	Testosterone may increase the anticoagulant activities of Acenocoumarol.	#1E61A5	0.364908456631846	1
Clozapine	Carbamazepine	0.356	-Inf	Major	2 (0/2)	Carbamazepine may increase the myelosuppressive activities of Clozapine.	#1E61A5	0.243272304421231	1
Gemfibrozil	Ursodeoxycholic acid	0.219	-Inf	None	2 (0/2)	The therapeutic efficacy of Ursodeoxycholic acid can be decreased when used in combination with Gemfibrozil.	#1E61A5	0.243272304421231	1
Sertraline	Carvedilol	0.167	-Inf	Moderate	4 (0/4)	The metabolism of Carvedilol can be decreased when combined with Sertraline.	#1E61A5	0.486544608842462	1
Phenytoin	Midazolam	0.143	-Inf	Moderate	1 (0/1)	The serum concentration of Phenytoin can be increased when it is combined with Midazolam.	#1E61A5	0.121636152210615	1
Cyclosporine	Verapamil	0.152	-Inf	Moderate	1 (0/1)	The metabolism of Cyclosporine can be decreased when combined with Verapamil.	#1E61A5	0.121636152210615	1
Cyclosporine	Sulfasalazine	0.6	-Inf	Major	1 (0/1)	Sulfasalazine may increase the nephrotoxic activities of Cyclosporine.	#1E61A5	0.121636152210615	1
Triamcinolone	Primidone	0.333	-Inf	Moderate	1 (0/1)	The metabolism of Triamcinolone can be increased when combined with Primidone.	#1E61A5	0.121636152210615	1
Doxycycline	Warfarin	0.144	-Inf	Moderate	3 (0/3)	The metabolism of Warfarin can be decreased when combined with Doxycycline.	#1E61A5	0.364908456631846	1
Diltiazem	Amlodipine	0.2	-Inf	Moderate	1 (0/1)	The metabolism of Amlodipine can be decreased when combined with Diltiazem.	#1E61A5	0.121636152210615	1
Fluconazole	Rifabutin	0.333	-Inf	Moderate	1 (0/1)	The serum concentration of Rifabutin can be increased when it is combined with Fluconazole.	#1E61A5	0.121636152210615	1
Cyclosporine	Phenytoin	0.235	-Inf	Moderate	1 (0/1)	The metabolism of Cyclosporine can be increased when combined with Phenytoin.	#1E61A5	0.121636152210615	1
Fluvoxamine	Acenocoumarol	0.38	-Inf	None	2 (0/2)	The metabolism of Acenocoumarol can be decreased when combined with Fluvoxamine.	#1E61A5	0.243272304421231	1
Pravastatin	Colchicine	1	-Inf	Major	1 (0/1)	Colchicine may increase the myopathic rhabdomyolysis activities of Pravastatin.	#1E61A5	0.121636152210615	1
Ergotamine	Carvedilol	0.333	-Inf	Moderate	1 (0/1)	Ergotamine may increase the atrioventricular blocking (AV block) activities of Carvedilol.	#1E61A5	0.121636152210615	1
Fluconazole	Cyclophosphamide	0.5	-Inf	None	1 (0/1)	The metabolism of Cyclophosphamide can be decreased when combined with Fluconazole.	#1E61A5	0.121636152210615	1
Mirtazapine	Clonidine	0.021	-Inf	Moderate	1 (0/1)	Mirtazapine may decrease the antihypertensive activities of Clonidine.	#1E61A5	0.121636152210615	1
Warfarin	Isoniazid	0.071	-Inf	Moderate	1 (0/1)	The metabolism of Warfarin can be decreased when combined with Isoniazid.	#1E61A5	0.121636152210615	1
Atorvastatin	Colchicine	0.75	-Inf	Major	2 (0/2)	The risk or severity of adverse effects can be increased when Colchicine is combined with Atorvastatin.	#1E61A5	0.243272304421231	1
Indomethacin	Losartan	0.103	-Inf	Moderate	3 (0/3)	The metabolism of Indomethacin can be decreased when combined with Losartan.	#1E61A5	0.364908456631846	1
Diltiazem	Carbamazepine	0.029	-Inf	Major	1 (0/1)	The serum concentration of Carbamazepine can be increased when it is combined with Diltiazem.	#1E61A5	0.121636152210615	1
Trazodone	Warfarin	0.286	-Inf	Minor	1 (0/1)	Trazodone may decrease the anticoagulant activities of Warfarin.	#1E61A5	0.121636152210615	1
Bisoprolol	Insulin glulisine	0.135	-Inf	Moderate	2 (0/2)		#1E61A5	0.243272304421231	1
Omeprazole	Chlordiazepoxide	0.5	-Inf	Moderate	1 (0/1)		#1E61A5	0.121636152210615	1
Atenolol	Insulin aspart	0.265	-Inf	Moderate	4 (0/4)		#1E61A5	0.486544608842462	1
Indomethacin	Warfarin	0.5	-Inf	Major	1 (0/1)	Indomethacin may increase the anticoagulant activities of Warfarin.	#1E61A5	0.121636152210615	1
Allopurinol	Acenocoumarol	0.308	-Inf	None	2 (0/2)	Allopurinol may increase the anticoagulant activities of Acenocoumarol.	#1E61A5	0.243272304421231	1
Phenytoin	Acenocoumarol	0.4	-Inf	None	1 (0/1)	Phenytoin may increase the anticoagulant activities of Acenocoumarol.	#1E61A5	0.121636152210615	1
Rifampicin	Gliclazide	0.2	-Inf	None	1 (0/1)	The serum concentration of Gliclazide can be decreased when it is combined with Rifampicin.	#1E61A5	0.121636152210615	1
Rifampicin	Nifedipine	0.5	-Inf	Major	1 (0/1)	The serum concentration of Nifedipine can be decreased when it is combined with Rifampicin.	#1E61A5	0.121636152210615	1
Indomethacin	Atenolol	0.537	-Inf	Moderate	3 (0/3)	Indomethacin may decrease the antihypertensive activities of Atenolol.	#1E61A5	0.364908456631846	1
Dextromethorphan	Moclobemide	0.091	-Inf	None	1 (0/1)	Moclobemide may increase the serotonergic activities of Dextromethorphan.	#1E61A5	0.121636152210615	1
Simvastatin	Amiodarone	0.429	-Inf	Major	1 (0/1)	The serum concentration of Simvastatin can be increased when it is combined with Amiodarone.	#1E61A5	0.121636152210615	1
Erythromycin	Acenocoumarol	0.118	-Inf	None	3 (0/3)	The serum concentration of Acenocoumarol can be increased when it is combined with Erythromycin.	#1E61A5	0.364908456631846	1
Salbutamol	Carvedilol	0.111	-Inf	Major	6 (0/6)	Carvedilol may decrease the vasoconstricting activities of Salbutamol.	#1E61A5	0.729816913263693	1
Sotalol	Levofloxacin	0.2	-Inf	Major	1 (0/1)	Levofloxacin may increase the QTc-prolonging activities of Sotalol.	#1E61A5	0.121636152210615	1
Propranolol	Glyburide	0.167	-Inf	Moderate	1 (0/1)	Propranolol may increase the hypoglycemic activities of Glyburide.	#1E61A5	0.121636152210615	1
Clozapine	Sertraline	0.432	-Inf	Major	2 (0/2)	The serum concentration of Clozapine can be increased when it is combined with Sertraline.	#1E61A5	0.243272304421231	1
Rifampicin	Dexamethasone	0.267	-Inf	Moderate	2 (0/2)	The serum concentration of Dexamethasone can be decreased when it is combined with Rifampicin.	#1E61A5	0.243272304421231	1
Celecoxib	Acenocoumarol	0.092	-Inf	None	2 (0/2)	Celecoxib may increase the anticoagulant activities of Acenocoumarol.	#1E61A5	0.243272304421231	1
Bisoprolol	Verapamil	1	-Inf	Major	1 (0/1)	The metabolism of Bisoprolol can be decreased when combined with Verapamil.	#1E61A5	0.121636152210615	1
Rosuvastatin	Gemfibrozil	0.143	-Inf	Major	1 (0/1)	The risk or severity of rhabdomyolysis. myoglobinuria. and elevated creatine kinase (CPK) can be increased when Gemfibrozil is combined with Rosuvastatin.	#1E61A5	0.121636152210615	1
Phenytoin	Rifampicin	0.222	-Inf	Major	1 (0/1)	The serum concentration of Phenytoin can be decreased when it is combined with Rifampicin.	#1E61A5	0.121636152210615	1
Simvastatin	Colchicine	0.36	-Inf	Major	2 (0/2)	Colchicine may increase the myopathic rhabdomyolysis activities of Simvastatin.	#1E61A5	0.243272304421231	1
Atenolol	Salmeterol	0.292	-Inf	Moderate	4 (0/4)	Atenolol may decrease the bronchodilatory activities of Salmeterol.	#1E61A5	0.486544608842462	1
Rifampicin	Atorvastatin	0.107	-Inf	Major	2 (0/2)	The metabolism of Atorvastatin can be increased when combined with Rifampicin.	#1E61A5	0.243272304421231	1
Atorvastatin	Fusidic acid	0.043	-Inf	None	2 (0/2)	The serum concentration of Atorvastatin can be increased when it is combined with Fusidic Acid.	#1E61A5	0.243272304421231	1
Fluvoxamine	Ergotamine	1	-Inf	Major	1 (0/1)	The risk or severity of adverse effects can be increased when Ergotamine is combined with Fluvoxamine.	#1E61A5	0.121636152210615	1
Warfarin	Hydrocortisone	0.2	-Inf	Moderate	1 (0/1)	Hydrocortisone may increase the anticoagulant activities of Warfarin.	#1E61A5	0.121636152210615	1
Cyclosporine	Rifampicin	0.167	-Inf	Major	1 (0/1)	The metabolism of Cyclosporine can be increased when combined with Rifampicin.	#1E61A5	0.121636152210615	1
Propranolol	Gliclazide	1	-Inf	None	1 (0/1)	Propranolol may increase the hypoglycemic activities of Gliclazide.	#1E61A5	0.121636152210615	1
Trifluoperazine	Levofloxacin	0.2	-Inf	Moderate	1 (0/1)		#1E61A5	0.121636152210615	1
Griseofulvin	Acetylsalicylic acid	0.13	-Inf	Minor	1 (0/1)		#1E61A5	0.121636152210615	1
Tacrolimus	Rifampicin	0.536	-Inf	Major	2 (0/2)	The serum concentration of Tacrolimus can be decreased when it is combined with Rifampicin.	#1E61A5	0.243272304421231	1
Metoprolol	Formoterol	0.167	-Inf	Moderate	1 (0/1)	The metabolism of Formoterol can be decreased when combined with Metoprolol.	#1E61A5	0.121636152210615	1
Propranolol	Verapamil	0.125	-Inf	Major	1 (0/1)	The metabolism of Propranolol can be decreased when combined with Verapamil.	#1E61A5	0.121636152210615	1
Epinephrine	Clomipramine	0.094	-Inf	Major	2 (0/2)	Clomipramine may decrease the antihypertensive activities of Epinephrine.	#1E61A5	0.243272304421231	1
Sucralfate	Ketoconazole	1	-Inf	Minor	1 (0/1)	Sucralfate can cause a decrease in the absorption of Ketoconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.	#1E61A5	0.121636152210615	1
Cyclosporine	Oxcarbazepine	0.267	-Inf	Moderate	1 (0/1)		#1E61A5	0.121636152210615	1
Amiodarone	Levofloxacin	0.143	-Inf	Major	1 (0/1)	Levofloxacin may increase the QTc-prolonging activities of Amiodarone.	#1E61A5	0.121636152210615	1
Warfarin	Metronidazole	0.059	-Inf	Major	1 (0/1)	The serum concentration of Warfarin can be increased when it is combined with Metronidazole.	#1E61A5	0.121636152210615	1
Warfarin	Levofloxacin	0.25	-Inf	Major	1 (0/1)	Levofloxacin may increase the anticoagulant activities of Warfarin.	#1E61A5	0.121636152210615	1
Haloperidol	Ketoconazole	0.111	-Inf	Major	1 (0/1)	The metabolism of Haloperidol can be decreased when combined with Ketoconazole.	#1E61A5	0.121636152210615	1
Theophylline	Acyclovir	0.036	-Inf	Minor	1 (0/1)		#1E61A5	0.121636152210615	1
Phenytoin	Mirtazapine	0.2	-Inf	Moderate	1 (0/1)	Phenytoin may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.	#1E61A5	0.121636152210615	1
Methylprednisolone	Phenobarbital	0.095	-Inf	Moderate	1 (0/1)	The serum concentration of Methylprednisolone can be decreased when it is combined with Phenobarbital.	#1E61A5	0.121636152210615	1
Erythromycin	Rifampicin	0.667	-Inf	Moderate	2 (0/2)	The metabolism of Erythromycin can be increased when combined with Rifampicin.	#1E61A5	0.243272304421231	1
Carbamazepine	Josamycin	0.2	-Inf	None	1 (0/1)	The metabolism of Carbamazepine can be decreased when combined with Josamycin.	#1E61A5	0.121636152210615	1
Moxifloxacin	Ziprasidone	0.333	-Inf	Major	1 (0/1)	Moxifloxacin may increase the QTc-prolonging activities of Ziprasidone.	#1E61A5	0.121636152210615	1
Imipramine	Terbutaline	0.167	-Inf	Moderate	1 (0/1)	The risk or severity of adverse effects can be increased when Imipramine is combined with Terbutaline.	#1E61A5	0.121636152210615	1
Lamotrigine	Rifampicin	0.041	-Inf	Moderate	1 (0/1)	The metabolism of Lamotrigine can be increased when combined with Rifampicin.	#1E61A5	0.121636152210615	1
Doxycycline	Insulin glulisine	0.057	-Inf	Moderate	2 (0/2)		#1E61A5	0.243272304421231	1
Tolterodine	Itraconazole	0.25	-Inf	Moderate	1 (0/1)	The serum concentration of Tolterodine can be increased when it is combined with Itraconazole.	#1E61A5	0.121636152210615	1
Salbutamol	Doxepin	0.242	-Inf	Moderate	1 (0/1)	The risk or severity of adverse effects can be increased when Doxepin is combined with Salbutamol.	#1E61A5	0.121636152210615	1
Halazepam	Itraconazole	1	-Inf	None	1 (0/1)		#1E61A5	0.121636152210615	1
Celecoxib	Lithium cation	0.083	-Inf	Major	1 (0/1)	The serum concentration of Lithium can be increased when it is combined with Celecoxib.	#1E61A5	0.121636152210615	1
Carbamazepine	Isotretinoin	0.048	-Inf	Moderate	1 (0/1)		#1E61A5	0.121636152210615	1
Allopurinol	Azathioprine	0.333	-Inf	Major	1 (0/1)	The serum concentration of the active metabolites of Azathioprine can be increased when Azathioprine is used in combination with Allopurinol.	#1E61A5	0.121636152210615	1
Disulfiram	Acenocoumarol	0.429	-Inf	None	1 (0/1)	The serum concentration of Acenocoumarol can be increased when it is combined with Disulfiram.	#1E61A5	0.121636152210615	1
Digoxin	Clarithromycin	0.062	-Inf	Major	1 (0/1)	The metabolism of Digoxin can be decreased when combined with Clarithromycin.	#1E61A5	0.121636152210615	1
Minocycline	Acenocoumarol	0.219	-Inf	None	1 (0/1)	Minocycline may increase the anticoagulant activities of Acenocoumarol.	#1E61A5	0.121636152210615	1
Indomethacin	Lithium cation	0.333	-Inf	Major	1 (0/1)	The serum concentration of Lithium can be increased when it is combined with Indomethacin.	#1E61A5	0.121636152210615	1
Tacrolimus	Ketoconazole	1	-Inf	Major	1 (0/1)	The serum concentration of Tacrolimus can be increased when it is combined with Ketoconazole.	#1E61A5	0.121636152210615	1
Digoxin	Alprazolam	0.375	-Inf	Moderate	1 (0/1)		#1E61A5	0.121636152210615	1
Clarithromycin	Colchicine	1	-Inf	Major	2 (0/2)	The serum concentration of Colchicine can be increased when it is combined with Clarithromycin.	#1E61A5	0.243272304421231	1
Propranolol	Rifampicin	0.5	-Inf	Moderate	1 (0/1)	The metabolism of Propranolol can be increased when combined with Rifampicin.	#1E61A5	0.121636152210615	1
Terbinafine	Acenocoumarol	0.045	-Inf	None	1 (0/1)		#1E61A5	0.121636152210615	1
Terbinafine	Rifampicin	1	-Inf	Minor	1 (0/1)	The serum concentration of Terbinafine can be decreased when it is combined with Rifampicin.	#1E61A5	0.121636152210615	1
